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 ABSTRACT 
 
Bovine leukosis virus is an oncogenic retrovirus of cattle that causes 
lymphosarcoma in a proportion of infected individuals. Currently the United 
States estimates are that 44% of dairy cattle and 10% of beef cattle are infected 
with the virus. Many states have voluntary control programs in place, but no 
mandatory or federal programs currently exist. This is dramatically different from 
many other industrialized, cattle producing countries that have government 
controlled, mandatory control and eradication programs in place. Many of these 
countries in Europe, Australia, and New Zealand have dropped the prevalence of 
viral infection to negligible levels.  
The inability to accurately detect infection in calves by serologic test 
methods due to the interference of colostral immunoglobulin has led to US 
control programs focusing on the identification of infected adults. The ease at 
which serologic methods can be used in adults has also removed attention from 
the potential role that persistent lymphocytosis may play on an infected premise. 
The goal of this body of work was to develop alternative methods that may be 
utilized on heavily infected farms to help in the control of BLV infection. The 
studies presented here focus on the utility of diagnostic tests in the identification 
of infected calves and the identification of adults with persistent lymphocytosis.  
 
 viii
  CHAPTER 1 
 
BOVINE LEUKOSIS VIRUS INFECTION IN CATTLE 
 
 
 
RETROVIRUSES AND THEIR CLASSIFICATION 
The Retroviridae family of viruses is a group of RNA viruses. The 
discovery of Human immunodeficiency virus (HIV) and the recognition of its 
devastating effects have focused attention on retroviruses for the past 25 years. 
Retroviral virions are spherical, enveloped viruses that are 80 – 100nm in size. 
There are 4 main genes that encode for the virion proteins present in all 
retroviruses. They are 5’- gag, pro, pol, env-3’. Some families may have 
additional genes encoding additional proteins required for viral function. One 
unique feature of the retroviruses is the reverse transcriptase and integrase 
encoded by the pol gene. Viral replication begins with the reverse transcription of 
the viral RNA to cDNA by the reverse transcriptase. During this process RNA is 
digested and serves to prime positive sense cDNA synthesis on the negative 
sense DNA transcripts. The integrase is responsible for the incorporation of the 
viral DNA into the host genome, making the virus a permanent component of the 
host genome. 
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 BLV-HTLV group 
Bovine leukemia virus (BLV) is a retrovirus of the BLV- HTLV group. In 
addition to the standard retroviral genes, BLV also contains additional genes tax 
and rex which are found in overlapping reading frames following the env gene. 
Both genes are necessary for gene expression.  The genome structure, 
nucleotide sequence of the provirus, and amino acid sequence of the structural 
and nonstructural proteins are very similar to that of human T cell lymphotropic 
virus (HTLV-1 and HTLV-2). Both BLV and HTLV-1 have a stable genome, 
distinctly unlike the more notable human retrovirus, HIV. Both viruses lack a 
chronic viremia, have a long “latent” period, and lack preferred sites of proviral 
integration (Kettmann et al., 1980; Grégoire et al., 1984). Despite the lack of 
preferred proviral integration sites, the tumors generated by both viruses in a 
single individual are typically monoclonal and have a single integration site 
(Kettmann et al., 1980; Kettmann et al., 1983). Both BLV (Kettmann et al., 1980) 
and HTLV-1 (Franchini et al., 1984) escape the immune response by low levels 
of viral replication. In BLV it appears that replication is blocked at the 
transcriptional level, but the mechanism has not been completely elucidated 
(Gupta et al., 1984; Tajima and Aida, 2000; Merezak et al., 2001; van den Heuvel 
et al., 2005).  
Cattle are infected with BLV through the transfer of blood and blood 
products that contain infected lymphocytes. Once infected cattle will develop a 
persistent lifelong antibody response; primarily to the gp51 envelope protein and 
the p24 capsid protein. B lymphocytes harbor the integrated provirus, but rarely 
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 express viral proteins on their cell surface. The exact site of viral replication and 
expression that drives the immune response remains elusive. One study 
suggested that this site was the spleen and regional lymph nodes (Van Der 
Maaten and Miller, 1978). This was refuted in a later study by the same group 
(Van Der Maaten et al., 1982). Another group has suggested that this site may 
be the mammary epithelial cells (Buehring et al., 1994). There is also evidence 
that cells of the monocyte/macrophage lineage may be able to harbor the virus 
(Schwartz et al., 1994; Doménech et al., 2000), as is the case with HTLV-1 
(Hoffman et al., 1992; de Revel et al., 1993). While much is known about the 
transmission, epidemiology, and outcome of viral infection, the sequence of 
molecular events immediately post-infection that allows BLV to elude the immune 
system remains unclear. 
In cattle infected with BLV only 1 of every 25,000 – 50,000 peripheral 
blood lymphocytes expresses viral proteins or has viral mRNA present in the cell 
cytoplasm (Mirsky et al., 1996). This block of viral expression appears to be at 
the transcriptional level as no viral products including proteins, or RNA is 
detectable in most circulating cells (Kettmann et al., 1980). This block of viral 
expression is crucial, allowing the majority of BLV-infected cells to escape the 
surveillance of the host immune system. Once infected with BLV, cattle mount a 
strong, persistent immune response; making it clear that there are some infected 
cells that must express viral antigens on a consistent basis. The source of the 
antigenic stimulus that drives the immune response remains controversial.  
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OUTCOME OF INFECTION WITH BLV 
 There are 3 main outcomes in cattle infected with BLV. The vast majority 
of animals will remain persistently infected with no outward signs of infection. 
There is debate as to whether BLV infection causes measurable production 
losses. Increased culling rate (Brenner et al., 1989; Pollari et al., 1993) and 
decreased milk yields (Brenner et al., 1989; D’Angelino et al., 1998) have been 
attributed to BLV infection. However, some studies contradict these claims (Wu 
et al., 1989; Rhodes et al., 2003). Approximately 29% of BLV-infected cattle will 
develop persistent lymphocytosis, while less than 5% of BLV-infected cattle will 
develop lymphosarcoma (Ferrer et al., 1979b). 
  
Persistent lymphocytosis 
 There are many reasons that cattle may develop lymphocytosis that are 
not BLV-associated. In addition a proportion of BLV-infected cattle with 
lymphosarcoma will develop lymphocytosis in association with their tumor 
process. The term persistent lymphocytosis (PL) refers to a benign elevation in 
lymphocyte count that accompanies BLV infection in a proportion of infected 
animals. Approximately 29% of cattle infected with BLV will develop persistent 
lymphocytosis and approximately 95% of animals with persistent lymphocytosis 
are BLV positive (Ferrer et al., 1979b). Persistent lymphocytosis is sometimes 
referred to as a preneoplastic syndrome, but there is no convincing evidence that 
PL cattle have an increased risk of developing lymphosarcoma. The lymphocytes 
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 present in PL are not neoplastic although they may have mild reactive changes 
consistent with normal blood smears in cattle. Lymphocytosis associated with 
BLV infection is defined as an elevation in lymphocyte count that is 3 or more 
standard deviations above the mean (Marshak et al., 1968). In general 
demonstration of lymphocytosis at 2 testing periods over 60 – 90 days apart is 
accepted as persistent.  
 Persistent lymphocytosis is considered to be a benign condition 
associated with BLV infection. For this reason it is often overlooked. However, 
these cows may serve as a greater reservoir of infection on a farm. The 
increased lymphocyte count is attributed to a 45-fold increase of infected CD5+ 
and a 99-fold increase in infected CD5- B cells (Mirsky et al., 1996). In addition it 
has been suggested that cows with PL may be a greater risk for passing BLV 
infection on to their calves in utero (Lassauzet et al., 1991; Agresti et al., 1993) 
and may suffer from decreased milk production, (Da et al., 1993) and alteration 
of milk components (Da et al., 1993; Motton and Buehring, 2003). 
There is good evidence that genetics are involved in the development of 
PL (Xu et al., 1993), but the expression is considered to be multifactorial. The 
time from infection to the development of PL is unknown. In one experimental 
infection trial 5/16 inoculated calves developed persistent lymphocytosis (Miller et 
al., 1972). Three calves developed persistent lymphocytosis at 4-6 months and 2 
at 13 months post inoculation. There is no work currently available that has 
evaluated the development of PL in naturally infected animals. 
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 Lymphosarcoma 
 The development of lymphosarcoma occurs in 1-5% of BLV-infected cattle 
(Ferrer et al., 1979b). Clinical signs associated with the development of 
lymphosarcoma are highly variable, as the affected organ will dictate the 
predominant clinical signs. Animals with BLV associated lymphosarcoma will 
commonly show lesions in the central or peripheral lymph nodes leading to 
lymphadenopathy. Lesions of the abomasum may lead to signs of cranial 
abdominal pain, melena, or abomasal outflow obstruction. Pelvic limb paresis 
progressing to paralysis can occur in animals with extradural spinal lesions. 
Retrobulbar lesions will cause protrusion of the globe resulting in exposure 
keratitis and eventually proptosis. Lesions of the right atrium may be mild and 
undetectable clinically, or may present with arrhythmias, murmurs, or heart 
failure. Lesions of the uterus may present as cases of reproductive failure. Lastly, 
lesions of the internal organs typically will involve the spleen, liver, or kidneys 
and ureters. Lesions of the spleen are often initially asymptomatic, but may result 
in rupture of the spleen and exsanguination into the peritoneal cavity. 
Lymphosarcoma of the liver is often asymptomatic. Disease of the kidney and 
ureter can lead to abdominal pain and the subsequent development of 
hydroureter or hydronephrosis and clinical signs associated with renal failure. 
 
DISEASE TRANSMISSION 
The transmission of BLV occurs through the movement of infected 
lymphocytes from infected to naïve animals. Cell free virus had not been 
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 documented in vivo. Infection may become established by various routes. 
Inoculation of blood-origin lymphocytes or whole blood from a BLV-infected 
animal by subcutaneous (Roberts et al., 1982a; Evermann et al., 1986), 
intramuscular (Evermann et al., 1986; Kelly et al, 1993), intravenous (Evermann 
et al., 1986; Klintevall et al., 1997), intradermal (Roberts et al., 1982a; Evermann 
et al., 1986), intrauterine (Roberts et al., 1982a), or intratracheal (Roberts et al., 
1982a) routes have all caused infection in BLV negative animals. Intravenous 
inoculation of infected kidney culture cells (Ungar-Waron et al., 1999) has also 
been shown to easily transmit viral infection. In one study inoculation with a cell 
free supernatant from BLV positive cell culture lymphocytes was used to infect a 
calf (Miller et al., 1972). 
Nasal secretions, bronchoalveolar lavage fluid, and saliva have been 
evaluated for the presence of provirus and their ability to transmit BLV. Provirus 
within lymphocytes has been isolated in the cellular fraction of bronchoalveolar 
lavage fluid, but not from the cell free fraction (Roberts et al., 1982b). Sheep and 
cattle inoculated with infected bronchoalveolar lavage fluid became infected but 
only 6/9 cattle and 1/6 sheep infected in this manner has detectable BLV in their 
bronchoalveolar lavage fluid (Roberts et al., 1982b).  
Bovine leukosis virus has been found in the nasal secretions of infected 
cattle by some researchers (Lucas et al., 1993; Roberts et al., 1982b), but not by 
others (Miller and Van Der Maaten, 1979). In one study, both sheep and cattle in 
contact with animals that shed the virus in the nasal secretions did not become 
infected despite documented infectivity of the nasal secretions (Lucas et al., 
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 1993). Infectivity of saliva has been documented (Ressang et al., 1982). In all 
cases the saliva from BLV positive animals was injected into naïve animals. In 
this unnatural setting the secretion was infectious. In one study, sheep that were 
in contact with a BLV cattle that shed virus in the saliva remained BLV negative. 
However ¼ calves in contact converted to BLV positive status (Ressang et al. 
1982). It is clear that some BLV positive animals will have infectious provirus 
present in respiratory secretions. However, natural contact studies suggest that 
this is a minor route of transmission in the majority of cases. 
A study that examined the infectivity of urine and feces found both to be 
noninfectious when injected into naïve sheep (Ressang et al., 1982). In this study 
the urine samples were spun in a centrifuge and the supernatant was used as 
the inoculum. The fecal samples were diluted sonicated, and spun in a 
centrifuge. The supernatant was utilized as the inoculum. Both of these 
processing methods may have actually disrupted or removed potentially 
infectious cells from the inoculums. Injection of 100 mls of urine from BLV 
positive animals into the peritoneum of susceptible sheep did not result in viral 
transmission (Miller and Van Der Maaten, 1979). Very little work has been done 
on the infectivity of feces and urine. There is no evidence to support that these 
excretions are routinely infectious. 
Reproductive tissues and fluids such as embryos, semen, and uterine 
fluids also have been evaluated for the presence of BLV provirus and their ability 
to transmit the virus. Researchers have found conflicting results. One 
epidemiologic study found natural service using BLV infected bulls to be a risk 
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 factor for transmission (Ritter, 1965). Another demonstrated the infectivity of 
semen from one BLV infected bull (Lucas et al., 1980). In this study the bull was 
collected using rectal massage and between 2-10 ml was injected 
intraperitoneally into sheep. Three of 11 sheep were infected with BLV by this 
route. In another study BLV status of the sire was found to have no effect on the 
BLV status of the progeny using either natural service or artificial insemination 
(Baumgartener et al., 1978). This is supported by a study that evaluated the risk 
of artificial insemination on a dairy herd. No increase in transmission could be 
attributed to the use of artificial insemination (Thurmond et al., 1983a). Infected 
fresh chilled semen from 4 BLV infected bulls was found to be non infectious in 
the 8 sheep which were intraperitoneally inoculated (Miller and Van Der Maaten, 
1979). This is supported by a study that intraperitoneally inoculated 32 sheep 
with 2-8 mls of pooled ejaculates from BLV infected bulls after freezing in liquid 
nitrogen (Kaja and Olson, 1982). In this study none of the sheep developed BLV 
infection. In addition Embryos collected from infected cows that were placed into 
negative recipients failed to produce BLV infection in either the recipient cow or 
the offspring (Eaglesome et al., 1982; Kaja et al., 1984). In all studies animals 
were exposed to the virus by an unnatural route, typically intraperitoneal 
injection. It is clear that some bulls shed potentially infectious BLV in semen. It is 
also documented that cows can become infected via intrauterine inoculation of 
infected lymphocytes (Roberts et al., 1982a). Based on this information, it is 
possible for cows to become infected by use of a BLV infected bull. It appears 
that some methods of collection, rectal massage vs. electroejaculator, may be 
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 more significant risks than others and some processing methods such as 
freezing semen in liquid nitrogen, may be protective.  
The majority of BLV transmission is horizontal. Close contact between 
BLV negative and BLV positive cattle has been thought to be a risk factor 
(Straub, 1978; Maas-Inderwiesen et al., 1978; Thurmond et al., 1983a). Many 
common farm practices have been implicated in viral transmission including 
tattooing, dehorning, rectal palpation, injections, and blood collection. It is 
possible that vectors such as tabanids and other large biting flies also may 
transmit the virus. Vertical transmission may occur transplacentally from an 
infected dam to her fetus, intrapartum by contact with infected blood, or 
postpartum from the dam to the calf through the ingestion of infected colostrum. 
 
Contact 
 Close contact has been considered to be a substantial risk factor for the 
transmission of BLV (Straub, 1978; Maas-Inderwiesen et al., 1978; Thurmond et 
al., 1983a). The concept of contact transmission has been supported in one 
study which found an increased transmission during the winter in a herd that was 
extensively managed on pasture during the summer and intensively managed in 
a barn during the winter (Wilesmith et al., 1980). However at least one study has 
found animal density played no role in increased transmission (Lassauzet et al, 
1990a). Survey demographic data also supports contact, as BLV is more 
common in large dairy herds and small beef herds (NAHMS 1997; NAHMS 
1999), both of which are typically more closely housed than their counterparts, 
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 large beef herds and small dairy herds. The exact reasoning behind this 
increased risk has not been elucidated. It has been demonstrated that infectivity 
of contaminated blood is time (Buxton et al., 1985) and dose (Evermann et al., 
1986) dependent. It seems likely that crowding of animals would enhance the 
ability of larger quantities of provirus to move from animal to animal more 
efficiently when they are closer together. 
 
Animal processing 
 Many veterinary husbandry practices that occur on farms have been 
implicated as risk factors for BLV transmission. Tattooing BLV negative sheep 
after BLV positive calves has been shown to be an effective method in 
transmitting BLV (Lucas et al., 1985). Tattoo inks have not been demonstrated to 
have any virucidal activity (Lucas et al., 1985). Gouge dehorning also has been 
demonstrated to be a risk factor (Lassauzet et al., 1990b; DiGiacomo et al., 
1985). One study found an increased risk of BLV infection in calves that were 
dehorned by gouge methods when compared to non-dehorned calves 
(Lassauzet et al., 1990b). The risk almost doubled when a calf was dehorned 
after a calf that was BLV positive. Another study evaluated 2 methods dehorning 
compared to a non dehorned negative control group (DiGiacomo et al., 1985). 
Within 3 months of dehorning 1/19 control calves, 7/22 gouge dehorned, and 
0/14 gouge dehorned followed by cautery and instrument disinfection had 
seroconverted to BLV positive status. One study attributed a decrease in BLV 
prevalence in a herd to changing dehorning methods from gouge dehorning of 
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 older calves to cautery of young calves during a time where colostral origin 
antibodies may aid in calf protection (DiGiacomo et al., 1987). 
 
Injections 
 Since blood is the major source of infectious provirus, injections seem a 
likely risk. Early investigations point to intravenous blood sampling as a risk 
factor for BLV transmission. One study found animals in which a blood sample 
was obtained immediately following a BLV positive animal had an 8 fold greater 
risk of becoming infected with BLV (Wilesmith et al., 1978). This group attributed 
80 - 90% of BLV transmission during the study period to blood sampling with 
multi-use needles. Another study evaluating BLV infection in 52 herds found 293 
BLV positive animals after a herd test (Maas-Inderwiesen, 1978). All positive 
animals were removed from their herds immediately. On a follow up test 3 
months later an additional 114 animals were found to be BLV positive. Of these 
78 animals had been housed next to a BLV positive animals and 49 had been 
samples immediately after a BLV positive animal. This gave rise to the suspicion 
that needle transmission of BLV may be important. 
 Unlike multi-use bleeding needles, there is little to support injection 
needles as a risk factor for BLV transmission. One study evaluated the ability of 
tuberculin needles and tuberculosis testing as a mode of transmission (Roberts 
et al., 1981). Fifteen cows and fifteen sheep that were tuberculin tested after a 
BLV positive cow failed to become infected. When tuberculin needles were 
intentionally contaminated with BLV positive blood and then used for tuberculin 
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 testing, 3/3 cows and 3/3 sheep became infected. Other studies have found no 
association between brucellosis vaccination (Lassauzet et al., 1990b) and other 
routine vaccinations (Thurmond et al., 1983c) with BLV infection. It has also been 
found that cleaning multi-use needles with cotton wool in between animals may 
prevent proviral transmission (Roberts et al., 1981). In this study needles were 
contaminated with blood from a BLV positive cow, wiped clean and used to 
tuberculin test sheep. They found that wiping needles with cotton wool prevented 
infection in 3/3 animals tested while cotton wool and water and cotton wool and 
alcohol only prevented infection in 2/3.  
 Contamination of blood based vaccines has also been shown to 
potentially transmit the virus (Rogers et al., 1988). In one case 13,959 doses of a 
tick fever vaccine was generated with the use of blood from a BLV infected calf 
that had a negative AGID test prior to vaccine production. In herds where the 
contaminated vaccine was used the BLV prevalence in vaccinated cattle was 
62% in dairy and 51.8% in beef compared to prevalences of 6.1% and 1.5% in 
non-vaccinated animals in the same herds.  
 
Rectal Palpation 
 Routine rectal examinations for the determination of health or pregnancy 
status using multiple use sleeves have been implicated as a potential risk for 
BLV transmission. Early studies laid the groundwork demonstrating that blood 
from a BLV positive animal may be infectious when deposited in the rectum of an 
uninfected animal. In one study transmission occurred in both cattle and sheep 
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 receiving inoculums of 500ml and 50ml blood per rectum, respectively (Henry et 
al., 1987). Another study placed 2 ml of infected blood on a rectal sleeve and a 
rectal examination was performed to simulate blood contamination more 
consistent with that obtained on a routine rectal examination (Hopkins et al., 
1988). Each examination was 30 seconds in length and was performed once 
weekly for three weeks. In all cases animals became BLV positive within 5 
weeks. In contrast one study found that the probability of seroconverting to BLV 
positive status following routine rectal examination was 0.034 and was not 
associated to the prevalence of infection at the time of rectal palpation 
(Lassauzet et al., 1989b). 
 Perhaps the most convincing study to date is one that evaluated 
transmission in a dairy herd over a 22 month period (Divers et al., 1995). In this 
study seronegative cattle were housed with seropositive cattle and identified only 
by neck chain. In this herd one group of cattle had rectal sleeves changed 
between cows and the other had no sleeves changed between rectal 
examinations. At the end of the study period cows palpated in the no sleeve 
change group had a 2.8 fold greater risk of BLV infection than the sleeve change 
group.  
 
Insects 
 Blood sucking insects have been considered a risk for the spread of BLV 
infection in cattle (Bech-Nielsen et al., 1978). Epidemiological studies are split on 
this point. One large study in France evaluated the incidence and prevalence of 
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 BLV infection in conjunction with horsefly density and geographical distribution 
(Manet et al., 1989). This study found a correlation between the incidence of BLV 
infection and the density of horsefly population. They also found a seasonal 
pattern with new infections higher during the times of peak horsefly activity. 
Another study demonstrated a seasonal effect with increased transmission 
occurring during the summer months. This combined with the identification of 
infected lymphocytes on the mouthparts of horse flies that had been feeding 
BLV-infected cows led the group to conclude that Tabanids were a substantial 
risk for BLV transmission (Bech-Nielsen et al., 1978). A United States study 
evaluating incidence of infection on a 200 cow dairy over a 15 month period 
found no evidence of a seasonal effect of BLV transmission (Thurmond et al., 
1983c) This is supported by a study conducted in a summer grazing and winter 
housed dairy which did not demonstrate an increase in proviral transmission 
during the grazing season (Wilesmith et al., 1980).  
Experimental studies highlight the potential for blood-sucking insects to 
serve as a mechanical vector (Buxton et al., 1982; Buxton et al., 1985; Ohshima 
et al., 1981). When inoculated subcutaneously after ingesting a blood meal the 
mouthparts from mosquitoes, stable flies, horn flies, horse flies and deer flies all 
have the capability of infecting cattle and sheep with BLV (Buxton et al., 1982; 
Buxton et al., 1985). In these studies sheep would consistently become infected 
when inoculated with lower numbers of infected mouthparts than cattle. Infectivity 
is also time dependent as mouthparts that were injected one hour or more after a 
blood meal failed to transmit the virus (Buxton et al., 1985).  
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 When more natural routes of insect exposure are examined, transmission 
is not as clear. In a study designed to test the interrupted feeding behavior of 
stable flies, 4 BLV negative calves remained negative after exposure to 75 bites 
from stable flies that had previously fed on a BLV positive cow (Buxton et al., 
1985). An additional study designed to simulate natural exposure placed BLV 
negative and positive cattle in an enclosure that only allowed animal contact by 
way of the flies. In this study no transmission of the virus occurred (Buxton et al., 
1985). A study that evaluated tabanid flies was able to demonstrate viral 
transmission in 2/3 lambs that received 131-140 fly bites over a 4 day period 
(Ohshima et al., 1981)   
 Summarizing the literature, it is clear that biting insects that have multiple 
blood meals on different hosts in a short period of time pose the greatest risk. 
Large numbers of bites from a heavily infected host over a short period of time 
are required for insect transmission to occur. This makes the total risk of BLV 
transmission from biting insects small.    
 
Transplacental 
 Vertical transmission of BLV across the placenta occurs in a proportion of 
BLV infected cattle. However, the rate at which this occurs is not clear. The rate 
of transplacental transfer in the published literature is highly variable, ranging 
from 0.0 – 26 % (Meas et al., 2002; Van Der Maaten et al., 1981b; Jacobsen et 
al., 1983; Kono et al., 1983; Piper et al., 1979) None of the studies documented 
that samples were truly precolostral using a quantitative test for passive transfer. 
 16
 While only one study drew samples from observed parturitions (Jacobsen et al., 
1983). In addition, many of these studies were performed in unnatural settings 
including a herd selected for a high prevalence of enzootic bovine leukosis (Piper 
et al., 1979) and another in which the pregnant cows were experimentally 
infected with the virus (Van Der Maaten et al., 1981b).  
 One potential cause for the wide range in the literature that has not been 
sufficiently evaluated is that all BLV positive cows may not have the same risk of 
passing the virus to their fetus. One study found in utero infection to be more 
likely in cattle with a blood lymphocyte count above 12,000 cells/µL during 
pregnancy and in those that developed malignant lymphoma (Lassauzet et al., 
1991). This is supported by 2 other studies. One found that 33% of fetuses in 
cows with lymphosarcoma were positive for BLV prior to birth (Ohshima et al., 
1981). Another suggests that transplacental infection may be more common in 
cows with persistent lymphocytosis (Agresti et al., 1993). In this study 5/18 
calves born to PL cows were BLV provirus positive at birth while 0/25 calves born 
to BLV positive aleukemic cows were infected at birth. Another study found a 
higher rate of transplacental transmission in cows that were co-infected with BLV 
and bovine immunodeficiency virus when compared to cows only infected with 
BLV (Meas et al., 2002). 
 An association between in utero infection and calf sex has been noted by 
one group (Thurmond et al., 1983a). In this study bull calves were more 
commonly infected in utero than heifer calves. Calf sex has not been evaluated in 
most in utero studies and a male predilection has not been demonstrated in 
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 studies on postnatal BLV infections (Baumgartener et al., 1975; Evermann et al., 
1980; Burridge et al., 1981). One study found no association of in utero infection 
with dam age, dam parity, breed, or time of seroconversion (Thurmond et al., 
1983a). Another study found no association between in utero infection and 
seropositivity to p24 antibodies (Lassauzet et al., 1991). 
 It appears that transplacental transmission of BLV in cattle is an 
uncommon event. It may be that cattle with higher lymphocyte counts, higher 
proviral loads, and those concurrently infected with other retroviruses may pose 
greater risks to their calves.  
 
Colostrum and milk 
 The effect of colostrum on calf BLV status has been previously 
investigated. In one study the rate of colostral transmission can be derived from 
the data although determining a colostral rate of transfer was not the intended 
purpose of the work. The data presented suggested colostral infection rates of 
7% were present (Piper et al., 1979). Two divergent conclusions have been 
drawn from the current body of literature. One suggests that colostrum is a risk 
factor for the transmission of BLV to neonatal calves (Miller and Van Der Maaten, 
1979; Ferrer and Piper, 1981). The other suggests that the antibody present in 
colostrum serves a protective role in preventing infection in the neonate (Van Der 
Maaten et al., 1981a; Lassauzet et al., 1989a). Infected lymphocytes are present 
in both colostrum and milk of BLV infected cattle and it has been shown that the 
oral ingestion of infected serum origin lymphocytes can transmit the virus early in 
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 life (Baumgartner et al., 1976; Van Der Maaten et al., 1981a). It has also been 
shown that the cellular component of colostrum and milk is capable of 
transmitting the virus when injected parenterally (Chung et al, 1986; Miller and 
Van Der Maaten, 1979). Despite these being unnatural routes of exposure, these 
studies highlight the potential for the transmission of the virus through infected 
colostrum and milk. This is particularly concerning during the first 24 hours of life 
because the neonatal gut will allow the absorption of macromolecules and cells.  
  Despite the potential for colostrum being a mechanism for BLV 
transmission, several studies suggest that the maternal antibody present in 
colostrum may have a protective role against BLV infection (Van Der Maaten et 
al., 1981a; Lassauzet et al., 1989a). One study demonstrated that calves fed 
blood origin lymphocytes in BLV antibody positive colostrum did not develop 
persistent BLV infection. The control group which was fed a smaller number of 
infected lymphocytes in BLV negative colostrum seroconverted within 2 months 
(Van Der Maaten et al., 1981a). In the same study, calves that were injected 
intradermally with a dose of infected lymphocytes that was 10-fold lower than the 
BLV antibody positive colostrum-fed study group were not as uniformly protected 
as the oral challenge group (Van Der Maaten et al., 1981a). Another study 
attributed the low level of transmission via colostrum and milk in calves with 
continual contact with BLV positive animals to colostral antibodies (Ferrer and 
Piper, 1981). Perhaps the most convincing study demonstrated that BLV 
antibody negative calves were 2.0 – 2.7 times more likely to be infected with BLV 
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 when they left the hutches than calves that acquired BLV antibodies via 
colostrum (Lassauzet et al, 1989a).  
 The ability of milk to harbor and transmit BLV has been investigated 
(Chung et al., 1986; Baumgartener et al, 1976; Rubino and Donham, 1984; 
Roberts et al., 1983). The majority of the studies utilized milk from BLV negative 
cows and added infected blood origin lymphocytes (Baumgartener et al, 1976; 
Rubino and Donham, 1984; Roberts et al, 1983). Infectivity on all of these studies 
was determined by injection of the suspension into sheep. Only one study 
actually evaluated the ability of milk origin lymphocytes to transmit the virus 
through intraperitoneal injection (Chung et al., 1986). In all studies, sheep that 
were injected with milk or milk/lymphocyte suspensions developed infection with 
BLV. These studies make it clear that milk is a potentially infectious fluid, but 
epidemiologic studies do not support colostrum and milk as a major source of 
transmission (Lassauzet et al, 1989a). In addition studies evaluating routes of 
exposure do not support oral exposure of BLV as a major route of infection 
(Roberts et al, 1982a).  
 
AVAILABLE TESTS FOR BLV INFECTION 
Many tests have been developed to detect BLV in infected cattle. The 
earliest tests were hematologic assays that indirectly detected infected animals. 
After the virus was identified, serologic assays and virus or provirus detecting 
assays were developed. 
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 Hematologic assays 
Lymphocytosis – Lymphocytosis is not a true test for BLV status. This test 
arose from the recognition that farms that had lymphosarcoma also had a 
proportion of cows that maintained a consistently high blood lymphocyte count 
(Table 1) (Bendixen, 1959). With this rudimentary understanding of the disease 
process many European countries began successful control programs.  The 
development of serologic tests dramatically improved both sensitivity and 
specificity for detection of infected cattle. One study suggests that BLV 
prevalence may be underestimated by up to 10-fold using hematologic 
techniques (Maas-Inderwiesen et al., 1978)  
Hematologic assays have fallen out of favor for more accurate testing 
modalities. Despite this, the detection of lymphocytosis may still have some utility 
in BLV control and eradication. Approximately 29% of BLV positive animals will 
develop a persistent lymphocytosis consisting of virally infected cells. A BLV 
positive, hematologically normal cow typically has approximately 2% of its 
lymphocytes infected with the virus (Mirsky et al., 1996). In contrast, a BLV 
positive animal with persistent lymphocytosis can be expected to have 
approximately 39% of its lymphocytes infected with the virus (Mirsky et al., 1996). 
Cattle with persistent lymphocytosis may serve as a larger reservoir of infection 
on a farm with a greater number of infected lymphocytes per unit of blood.  
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 Antibody tests 
 After viral exposure it typically takes 6 - 14 weeks to develop a detectable 
antibody response to BLV (Evermann et al., 1986). All commercial test kits rely 
on the detection of gp51 and/or p24 antibodies. Most of the tests currently on the 
market are gp51 tests. Cross-reactions to the serologic assays have not been 
documented, nor has infection without antibody production. Positive serology 
results are consistently present in cattle infected with BLV and cattle not infected 
with BLV are nearly uniformly negative with regard to their serologic status. 
However, false-positive and false negative tests do occur under predictable 
situations. False-positive tests are most commonly seen in calves that receive 
colostrum from infected dams (Ferrer and Piper, 1981; Van Der Maaten et al., 
1981a; Lassauzet et al., 1991). The maternal origin antibody may be detectable 
for up to 6 months (Burridge et al., 1982a). False negative test results are seen 
most commonly in periparturient cows (Burridge et al., 1982b). It is postulated 
that during colostrogenesis it is possible for a cow to move enough serum 
antibody into the mammary gland that BLV antibody levels drop below a 
detectable range (Burridge et al., 1982b). This phenomenon has been 
documented using the AGID and has not been tested using more sensitive 
serologic test methods. As always, collection and labeling error or laboratory 
error may play a minor role in generating false positive or false negative test 
results. 
 Interpretation of sensitivity and specificity data on serologic BLV tests 
should be approached with some caution. Reported data for all of the serologic 
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 methods has similar ranges in both sensitivity and specificity. However, the 
sensitivity of the assays is clearly different when evaluated in comparative 
studies (Martin et al., 2001; Choi et al., 2002). Currently, there is not one test that 
is accepted as the gold standard and all available test modalities present at least 
minor problems that may affect sensitivity and specificity of the test. Based on 
technology alone, the western immunoblot should be the most accurate followed 
by the ELISA and finally the AGID. Comparative studies have supported this 
ranking (Choi et al., 2002). Despite this, the ELISA is probably the most common 
test run to determine BLV status and the AGID is still the required test for many 
import/export situations.  
AGID – The agar gel immunodiffusion test relies on the precipitation of 
antigens for test results. The agar gel immunodiffusion was an early antibody 
detection test for determining BLV status. Early tests that relied on the detection 
of p24 lacked the sensitivity of the newer tests that identify gp51. The gp51 test 
has a reported test sensitivity of 0.946 – 0.985 and a specificity of 0.964 – 0.998 
(Jacobsen et al., 1985; Monke et al., 1992). This test has an incubation time of 
48-72 hours. Reading at the latter test time is responsible for the higher reported 
sensitivity and specificity data (Monke et al., 1992).  
ELISA – There are 2 ELISA test kits currently on the market in the United 
States. Both tests detect the gp-51 surface glycoprotein. Manufacturer reported 
sensitivity and specificity are similar for the two tests are similar. Side by side 
comparisons have not been performed. This test takes less time to run than the 
AGID, typically under 1 hour. Most test kits require the use of a plate reader, 
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 restricting their use to laboratory settings. The improved sensitivity of the ELISA 
conforms to the World Health Organization’s requirements for use on pooled 
samples of up to 10 animals. The ELISA has also been documented to perform 
similar to serum on milk samples (Çarli et al., 1993). 
Western immunoblot – Recent work suggests that this test is more 
sensitive and specific than both the ELISA and the AGID. However, this study 
used the method as the gold standard in the study so sensitivity and specificity 
data were not generated (Choi et al., 2002). Previous studies on the western blot 
suggest a sensitivity of 0.974 of and a specificity of 0.994 (Kittelberger et al., 
1999). The western blot only gives reliable results for p24 antigen (Walker et al., 
1987; Kittelberger et al., 1996). The gp51 antigen appears to be degraded during 
the electrophoresis portion of the procedure. This may affect overall sensitivity of 
the test in that gp51 is the major antigen that cattle respond to immunologically. 
Historically responses to p24 were not reliably detected. This may be linked to 
the overall sensitivity of earlier methodologies. 
 
Antigen tests 
Polymerase chain reaction – PCR relies on the amplification of specific 
DNA sequences unique to the BLV provirus. Amplification products can then be 
visualized in a 2% agarose gel by ethidium bromide staining and ultraviolet 
transillumination. Polymerase chain reaction assays are relatively new to BLV 
diagnostics. There are multiple methodologies using different primers yielding 
some differences in sensitivity (0.627 – 0.984) and specificity (0.89 - 1.0) (Eaves 
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 et al., 1994; Nagy et al., 2003). Since the PCR amplifies the DNA present in the 
sample, conversion to PCR positive status has been postulated to occur more 
rapidly than seroconversion (Kelly et al., 1993; Klintevall et al., 1994). This has 
not held true in all studies (Nagy et al., submitted b). The detection of provirus 
instead of antibody and the ability to detect small quantities of provirus makes 
this test viable in neonates, periparturient cows, and potentially in animals with 
recently acquired infections that have yet to seroconvert. The current cost of the 
PCR is too expensive for routine use of the test. 
 
STATUS OF THE UNITED STATES 
The lack of an official BLV surveillance program has made estimating 
national prevalence of viral infection difficult. In 1975 a survey involving 4,394 
dairy cattle in 100 herds and 2,794 beef cattle in 50 herds found BLV infection 
present in 66% of the dairy and 14% of beef herds (Baumgartener et al., 1975). 
Overall, 10.2% of the dairy cattle and 1.2% of the beef cattle tested were 
positive. In this study dairy herds with less than 50 cows tended to have the 
highest prevalence of infection. However, very few herds had over 100 cows. 
Another study evaluating prevalence in herds in 5 states found a BLV prevalence 
of 28.2 % in dairy and 2.6% in beef herds (House et al., 1977). This study found 
no association of prevalence to herd size. Production type, age, and previous 
cases of lymphosarcoma in the herd were associated with BLV prevalence. 
Prevalence was higher dairy herds, older cows and in herds that had 
experienced at least one case of lymphosarcoma.  
 25
 In 1996 the National Animal Health Monitoring System (NAHMS) 
conducted a study on the prevalence of BLV in United States Dairy Herds 
(NAHMS, 1997). The study included data from randomly selected herds with 30 
cows or more. Twenty states were involved and the study represented 79% of 
the US dairy cattle population at that time. The study revealed that 89% of herds 
had BLV-infected cows on the premises and the prevalence of BLV infection in 
US dairy cattle was estimated to be 44%. Of infected herds 16.9% had 75% or 
more of the cows infected and 44% of herds had at least 50% of the cows 
infected.  
In 1997 NAHMS conducted a similar study in United States beef herds. 
The study included data from 2713 operations in 23 states (NAHMS, 1999). The 
total numbers of animals enrolled were not high enough to be representative of 
the national beef cattle population. However, these data are the best we have to 
date on beef cattle in the US. In this study, 38% of herds had BLV-infected cattle 
and 10% of all animals tested were infected with the virus. Unlike dairy, the 
majority of infected beef herds had low prevalence of infection with the herd. Of 
herds tested 56% had less than 25% of the cattle infected.  
At slaughter, mature cows are second to bob veal in the percentage of 
condemnations, ranging from 2.11 – 2.77% per year from 1998-2002 
(USDA:FSIS Animal disposition reporting system). Malignant lymphoma was the 
single highest cause of cow condemnations every year in these years (Table 2).  
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 TRADITIONALLY RECOMMENDED CONTROL PROGRAMS 
The original control and eradication programs for BLV were focused on 
identification and culling of hematologically positive cattle (Bendixen, 1959). 
Utilizing these methods many countries were thought to have substantially 
decreased BLV prevalence prior to the identification of the virus and 
development of more accurate serologic tests. Serology has better sensitivity and 
specificity in identification of BLV infected cattle. Once serologic tests became 
available programs centered on the culling of serologically positive cattle. 
 In some herds the prevalence of BLV infection makes culling all positive 
cattle cost prohibitive. In this light test and segregation programs evolved. The 
earliest serology based test and segregation program documented success of 
this method in the adults, but failure in the calves of a single herd (Van Der 
Maaten and Miller, 1979). In this herd segregation of positive and negative 
animals over a 12 month period led to only 4/27 new infection, with 2 of them in 
purchased animals of unknown status. In the calves, 6/8 calves converted to 
seropositive status over a 7 month period. A control herd that tested without 
segregation found 9/16 cows seroconvert during a time period in which the test 
herd only saw 1/18, suggesting the positive effect of segregation. The same 
researchers demonstrated similar results in a research facility and a commercial 
breeding service. 
An experiment evaluating a test and segregation protocol on 6 commercial 
dairy herds demonstrates the potential for these programs (Shettigara et al., 
1989). In this study six herds were tested using the gp51 AGID at 6 month 
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 intervals. This study involved segregation of BLV negative and BLV positive 
cattle by a minimum of 200 yards. An additional group to quarantine cows of 
unknown status was also required. New additions were tested 30 days prior to 
entry and remained in the quarantine herd until a second negative test at least 60 
days from entry into the quarantine herd. In 3 herds with initial prevalences of 
7.1%, 2.8%, and 7.1%, herd negative status was achieved after one test and 
segregate cycle. In 2 herds with initial prevalence of 7.9% and 12.2%, herd 
negative status was achieved after 3 test and segregate cycles. In the last herd 
with an initial prevalence of 24.5%, the first herd negative test was achieved at 4 
test and segregation cycles. However, problems with keeping the groups 
separate led to additional reactors and complete negative status was not 
achieved for a total of 9 test and segregation cycles.  
An experiment on test and cull in 5 herds demonstrated the ability to use 
the AGID in test successfully in BLV eradication (Mammerickx et al., 1978). In 
this study 5 herds with varying prevalence all achieved BLV free status within 3 
test and cull cycles. Two herds with prevalences of 2% and 10% achieved 
negative status after 1 cycle, 1 herd with an initial prevalence of 22% achieved 
negative after 2 cycles and 2 herds with prevalence of 37% and 56% achieved 
negative status after 3 cycles.    
 In addition to test and cull or test and segregation programs, 
managemental changes without segregation and culling practices have been 
evaluated in a commercial dairy herd (Sprecher et al., 1991). In this study single 
use needles, single use rectal sleeves, disinfection of tattoo pliers in between 
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 calves, electric cautery for dehorning, heat treatment of colostrum, and cessation 
of dump milk feeding were instituted. Within the 2 year study the prevalence of 
BLV in all cohorts decreased. Overall prevalence in the age groups studied (0-1st 
parturition) decreased significantly from 0.44 to 0.17. 
 Selective culling based on in vitro antigen expression from infected cows 
has also been evaluated (Molloy et al., 1994). These researchers found that 
culling of BLV positive cows with the highest in vitro antigen expression had the 
ability to considerably decrease BLV transmission on farms. Cows with higher 
antigen expression were also found to have higher lymphocyte counts and higher 
proviral loads based on serial dilution PCR. 
  
PROBLEMS WITH TRADITIONAL CONTROL PROGRAMS  
Based on this information, it is clear that test and segregate and test and 
cull programs can be effective, even in high prevalence herds. However, the lack 
of indemnity, the high prevalence of nation wide infection, and the lack of 
mandatory control programs, cripples BLV control at the level of the farm. In 
addition control programs rely heavily on serologic detection of BLV which is 
adequate in adults, but unreliable in calves.  
There is currently no incentive, financial or otherwise, to entice a 
commercial cattleman to eradicate BLV in their herd. National prevalence is so 
high that it is almost as likely to buy a BLV positive cow as a BLV negative cow 
during the purchase of a cow of unknown status. Since the negative outcome of 
viral infection is so rare, many people have trouble finding the incentive in being 
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 BLV free. Test and cull programs can become financially crippling in herds with a 
BLV prevalence over 10%. Test and segregation programs are extremely 
laborious. If strict adherence to the segregation procedures is not followed, 
failure to control viral infection in the herd may result (Shettigara et al., 1986). 
Even programs that routinely survey cattle for BLV can be foiled by the latent 
period. The time from viral infection to serologic detection can be as long as 90 
days if the infectious inoculum is small (Evermann et al., 1986). This lag time is 
sufficiently long to allow for the accrual of new infections even if positive animals 
are removed from the herd once detected. The isolation of purchased additions 
from the rest of the herd can be problematic in the lag time to positive tests. 
Failure to isolate and repeatedly test can result in program failure (Shettigara et 
al., 1986). The rapid results documented in the early control and eradication 
studies are misleading. In the majority of cases, studies required testing over 
multiple years to become BLV free. Compliance was often a problem in 
commercial herds, resulting in delayed attainment of BLV free status or lost 
status. The Finnish eradication program is an example of the complexities of test 
and cull programs. Despite a stringent test and slaughter program with an 
indemnity in place, it took 30 years to completely eradicate BLV from Finland 
(Nuotio et al., 2003).  
Traditional control programs rely on serology to detect infected individuals. 
On the surface, this appears to be adequate when you consider that once a cow 
becomes infected with the virus they develop a life long antibody response to 
BLV. However, these programs do not have an adequate way to address 
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 calfhood infection. Calves that have received colostrum from infected cows will 
test positive to BLV serologic tests due to the absorption of colostral origin 
antibodies (Piper et al, 1979; Burridge et al, 1982a). Detection of this maternal 
origin antibody may last as long as 6 months (Burridge et al., 1982a). In most 
commercial dairy herds calves leave individual calf hutches for small group 
housing by 8 weeks of age. This loss of quarantine may allow for viral spread 
through a group of animals if there is a BLV positive calf present at the time the 
calves are moved to group housing. Problems associated with identifying BLV 
infection in neonatal calves have shifted the focus of control programs to the 
adult herd. This may be a critical financial loss to the farmer as substantial 
investment in time and materials is invested in each heifer calf prior to 
identification of infected replacements. 
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 CHAPTER 2 
 
USE OF A POLYMERASE CHAIN REACTION ASSAY TO 
DETECT BOVINE LEUKOSIS VIRUS IN DAIRY CATTLE 
 
 
 
INTRODUCTION 
Bovine leukosis virus (BLV) is a retrovirus of cattle belonging to the BLV-
HTLV group. This oncogenic virus is transmitted from infected cattle to naïve 
cattle via blood-to-blood transfer. Transmission can occur during the course of 
daily farm activities such as tattooing (Lucas et al., 2001) and dehorning 
(DiGiacomo et al., 1985; Digiacomo et al., 1987), and by reuse of contaminated 
rectal sleeves (Henry et al., 1987; Hopkins et al., 1988; Divers et al., 1994) or 
hypodermic needles (Wilesmith et al., 1979). Transmission by tabanid flies has 
also been documented (Manet et al., 1989; Ohshima et al., 1981).  
Serologic methods for diagnosis of BLV infection, such as agar gel 
immunodiffusion test (AGID) and ELISA, are commonly used to identify infected 
animals. These tests are sensitive (ELISA, 0.98; AGID, 0.946 to 0.985) and 
specific (ELISA, 1.0; AGID, 0.964 to 0.998) for detection of infection (Jacobsen et 
al., 1985; Monke et al., 1992; Field testing data set for USDA license, VMRD Inc, 
Pullman, WA). Despite the availability of tests that are both sensitive and specific 
for BLV, diagnosing infections in neonates and periparturient cows remains 
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 problematic (Burridge et al., 1982a; Evermann and Jackson, 1997; Ferrer et al., 
1977; Johnson and Kaneene, 1991a). Passive transfer of colostral 
immunoglobulin from BLV-positive cows to their offspring may cause false-
positive serologic test results, which persist for the first 6 months of life (Burridge 
et al., 1982a; Burridge et al., 1982b). Consequently, testing by serologic methods 
is not reliable in post-colostral neonatal calves, severely limiting our ability to cull 
infected calves prior to substantial financial investment in those animals. 
Relying on serologic tests to determine BLV status of recently purchased 
cattle is also problematic.  Seroconversion may not develop for as long as 90 
days following experimental viral exposure (Evermann et al., 1986). The inability 
to detect BLV in recently exposed cattle forces prolonged isolation of recently 
purchased cattle to assure that BLV-positive animals are not introduced to the 
herd. Most farms lack the facilities and the commitment to impose on-farm 
quarantine periods of long duration. 
Polymerase chain reaction (PCR) assays may eliminate these concerns, 
because PCR can detect BLV provirus despite the presence of maternal antibody 
(Agresti et al., 1993). Polymerase chain reaction assays detect small quantities 
of virus, potentially leading to fewer false negative tests in recently exposed 
animals. The purpose of the study reported here was to evaluate the use of a 
PCR assay to detect BLV in an established dairy herd with a high prevalence of 
BLV. 
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 MATERIALS AND METHODS 
 Cows – 223 adult dairy cows owned by the University of Missouri 
Foremost dairy were used in this study. The study was approved by the 
Institutional Animal Care and Use Committee. 
Laboratory specimens – Blood samples for ELISA and PCR assay were 
collected simultaneously.  Samples for ELISA were collected into tubes without 
anticoagulant.  Serum was separated and stored at 4°C for further analyses.   If 
an initial ELISA result was negative, a second ELISA was performed 
approximately 95 days later to confirm that the cow was not infected with BLV.  
Samples for PCR assay were collected into tubes containing EDTA.  
Samples were stored at 4°C and processed within 48 hours.  Lymphocytes were 
isolated by use of a commercially available erythrocyte lysis (EL) buffer 
(Erythrocyte lysis buffer, Qiagen Inc, Valencia, CA). Lymphocytes were washed 3 
times with EL buffer and stored at –70ºC for subsequent analysis.  The DNA was 
extracted by use of a commercially available kit (QIAamp DNA mini kit, Qiagen 
Inc, Valencia, CA) following the manufacturers’ protocol. 
ELISA – A commercial assay (Bovine leukemia virus antibody test kit, 
ELISA, VMRD Inc, Pullman, WA) was used to detect of BLV antibodies. A 
positive test result was defined as a sample-to-positive ratio (S:P) > 0.5 and a 
negative test result was defined as a S:P < 0.5, with S:P calculated as  
 
S:P =     (sample absorbance − mean negative control absorbance)
                    (positive control absorbance − mean negative control absorbance) 
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 PCR assay – Forward (5'-TGG CTA TCC TAA GAT CTA CTG-3') and 
reverse (3'-AGA GGG AAC CCA GTC ACT GTT-5') primers were selected on the 
basis of a published report (Klinteval et al., 1994). The DNA sequences were 
amplified in a 25-µl reaction mixture containing 0.5µM of each primer and 1.0 unit 
Taq (HotStarTaq, Qiagen Inc, Valencia, CA) DNA polymerase in the 
manufacturer's buffer, which contained 2.0mM MgCl2 and 0.2mM (each) dNTPs. 
The reaction was performed in a programmable thermocycler.( Perkin-Elmer 
9700, Perkin-Elmer Inc, Shelton, CT) An initial incubation of 12 minutes at 95ºC 
was followed by 10 cycles of denaturation at 95ºC for 30 seconds, annealing at 
70ºC for 30 seconds, and extension at 72ºC for 90 seconds. Annealing 
temperature was reduced by 1ºC each cycle. An additional 30 cycles of 
denaturation at 95ºC for 30 seconds, annealing at 58ºC for 30 seconds, and 
extension at 72ºC for 90 seconds were performed, followed by a final extension 
at 72ºC for 7 minutes. Amplification with BLV-specific primers yielded a product 
of 330 base pairs. Amplification products were isolated in a 2% agarose gel and 
stained with ethidium bromide (Sambrook et al., 1989).  Each batch was 
performed with known positive and negative samples as controls. 
Data analysis – Sensitivity, specificity, predictive values of positive and 
negative tests and percentage of cows correctly classified by PCR assay were 
calculated with standard epidemiologic methods (Tyler and Cullor, 1989). A BLV-
positive cow was defined as having a positive ELISA result. A BLV-negative cow 
was defined as having 2 sequential negative ELISA results. Cows with initial 
negative ELISA results that were positive on the second test were not included.  
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 True positive, true negative, false positive, and false negative rates were also 
calculated. Ninety-five percent confidence intervals (CI) were calculated for 
sensitivity and specificity (Daniel, 1999). Positive predictive values (PPV) and 
negative predictive values (NPV) at all possible prevalences were calculated as:  
 
PPV =    (sensitivity X prevalence) 
  ([sensitivity X prevalence] + [{1 – specificity} X {1 − prevalence}]) 
 
NPV =    (specificity X [1 − prevalence]) 
   ([specificity X {1 – prevalence}] + [prevalence X {1 – sensitivity}]) 
 
False negative test rates for serial tests were calculated as:  
 
False negative rate = (1 − sensitivity)number of tests (smith, 1995)  
 
RESULTS 
Polymerase chain reaction and ELISA results were positive for 121 cows 
and were negative for 43 cows.  Fifty-nine cows had a positive ELISA result, but 
a negative PCR assay result.  No cows had a negative ELISA result and a 
positive PCR assay result. Sensitivity and specificity for the PCR assay were 
0.672 (95% CI, 0.611, 0.733) and 1.00, respectively. A CI was not calculated for 
specificity because performance of the PCR assay resulted in no false positives.  
Prevalence of BLV in this herd was 0.807.  Positive and negative predictive 
values were 1.00 and 0.421, respectively.  The percentage of cows correctly 
 36
 classified by PCR assay was 73.5%.  The PPV and NPV at all possible 
prevalences of infection for cows infected with BLV were determined (Figure 1).   
In populations with an initial prevalence of BLV of 5%, 10%, and 15%, 
serially testing each animal twice by use of the PCR assay can decrease 
prevalence to 0.5%, 1.1%, and 1.6%, respectively (Figure 2). Testing each 
animal 3 times will decrease prevalence to 0.2%, 0.4%, and 0.5%, respectively.  
Cattle that have positive PCR assay results are removed after each test. 
 
DISCUSSION 
In this study, use of a PCR assay was evaluated in a dairy herd with a 
high prevalence of BLV. Specificity of the PCR assay in determining BLV status 
in adult cows in this herd was ideal; hence PPV was ideal. The PPV of the PCR 
assay was independent of prevalence because specificity was 1.00.   
Consequently, a positive test result by use of PCR assay indicates that the cow 
tested is infected with BLV. Sensitivity of the PCR assay used in this study was 
low. Consequently, NPV was also low, making the PCR assay unreliable in herds 
with a high prevalence of BLV. The NPV is dependent on prevalence and is 
improved in populations with lower prevalence of disease.  
Performance of the PCR assay was promising and it may provide a useful 
adjunct to traditional testing programs. However, in most circumstances serologic 
tests will be superior to the PCR assay because higher sensitivity (> 95%) will 
expedite identification of BLV-infected animals. Potential applications of the PCR 
assay may be restricted to 3 specific situations in clinical practice. First, the PCR 
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 assay could be used to detect BLV in neonatal calves with passive transfer of 
maternal antibodies against BLV. Second, the PCR assay could be used as a 
confirmatory test in valuable animals that may otherwise be culled as a result of a 
positive serologic test. Third, the PCR assay could be used to identify cattle that 
were recently exposed to BLV, before seroconversion develops. However, to our 
knowledge, there is no available data to support the hypothesis that a PCR assay 
will detect BLV-positive cattle before seroconversion. 
Polymerase chain reaction assay also may be of use in neonatal calves. 
Calf BLV-status cannot reliably be determined by use of serologic tests until 6 
months of age (Burridge et al., 1982a; Burridge et al., 1982b). This is undesirable 
because infected and noninfected calves would likely be commingled at 8 weeks 
of age permitting amplification of low prevalence infections. A strategy to remove 
BLV-positive cattle solely on the basis of serologic status may be unsuccessful 
because of the prolonged duration that may be required for seroconversion 
following exposure to BLV. Despite being seronegative, infected calves may 
continue to be a source of BLV throughout the incubation period. As new 
seropositive carriers are removed, new incubationary carriers will have already 
been added to the group and will serve as reservoirs for infection. 
The PCR assay can identify BLV in calves with maternally acquired 
antibody. Calves may be tested before commingling, eliminating the potential for 
horizontal transmission. Detection of infection by use of the PCR assay in 
experimentally infected cows suggests that the incubation period for BLV may be 
as short as 1 week (Kelly et al., 1993). Therefore, the initial PCR assay could be 
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 completed at 2 weeks of age. Retesting BLV-negative calves at 5 weeks of age 
would detect calves that may have been incubating BLV when the initial test was 
performed. This diagnostic strategy would facilitate early removal of BLV-positive 
calves. The shortened interval between infection and a confirmed diagnosis 
would eliminate incubationary carriers, assuring that only BLV-negative heifers 
enter the milking herd. Raising BLV-negative replacement heifers is crucial to 
decreasing BLV prevalence within a herd. 
Serial testing could be used to increase the accuracy of testing 
procedures when applying a PCR assay to BLV control programs. Serial PCR 
assays can decrease the rate of false negative tests. In populations with low 
prevalence of BLV, 2 consecutive tests will reduce the false negative rate to an 
acceptable level, whereas 3 consecutive tests will reduce prevalence to a 
clinically unimportant level. In populations with high prevalence of BLV, serial 
testing could improve the ability to identify all infected cattle.  
Early removal of BLV-positive calves is important to dairy herd 
management. Rapid seroconversion to BLV-positive status once heifers reach 
the milking herd has been reported (Piper et al., 1979). This may represent 
exposures that developed before heifers entered the milking herd, indicating that 
neonate and juvenile transmission of BLV may be more important than previously 
recognized. The PCR assay may be of use in detecting BLV in recently exposed 
cattle and neonatal calves. In both of these groups, results of serologic testing 
may be inaccurate. However, serologic methods of BLV detection are more 
sensitive for routine screening of adult cattle.  
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 CHAPTER 3 
 
ASSOCIATION BETWEEN THE STRENGTH OF SEROLOGIC RECOGNITION 
OF BOVINE LEUKOSIS VIRUS AND LYMPHOCYTE COUNT IN BOVINE 
LEUKOSIS VIRUS-INFECTED COWS 
 
 
 
INTRODUCTION 
Bovine leukosis virus (BLV) is an oncogenic retrovirus of cattle. Transfer 
of lymphocytes from infected cattle to naïve cattle spreads the virus. Many 
common management practices including gouge dehorning (DiGiacomo et al., 
1985; Digiacomo et al., 1987), ear tagging, and tattooing (Lucas et al., 2001) 
have been implicated as mechanisms of viral transmission (Johnson and 
Kaneene, 1991b; Thurmond, 1991). Alternatively, the virus may also be 
transmitted by insects (Buxton et al., 1982; Buxton et al., 1985; Manet et al., 
1989; Ohshima et al., 1981), natural service (Johnson and Kaneene, 1991b), 
transplacental transmission from dam to the fetus (Van Der Maaten et al., 1981b; 
Thurmond et al., 1983a; Piper et al., 1979; Jacobsen et al., 1983), and ingestion 
of infected colostrum (Ferrer and Piper, 1981). The 1996 National Animal Health 
Monitoring System’s Dairy 96 study confirmed that 89% of U.S dairy herds were 
endemically infected with BLV (NAHMS, 1997). Of these positive herds 75% and 
44% had herd prevalences above 25% and 50% respectively. 
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 Among infected cattle, a subset will develop persistent lymphocytosis 
(PL), a benign lymphoproliferative condition. The estimated prevalence of PL in 
BLV infected cattle is 29% (Ferrer et al., 1979a). PL is more prevalent in cattle of 
certain lineages. Persistent lymphocytosis rates of up to 88% have been 
documented within some familial groups (Ferrer et al., 1979a). The presence of 
PL has not been definitively associated with the development of clinical 
lymphosarcoma (Ferrer et al., 1974; Abt et al., 1975). However, PL may still be 
clinically important because the virus is transmitted through infected lymphocytes 
(Gotze et al., 1956). A logical assumption is that cattle with lymphocytosis pose a 
greater risk to the herd. Cows with PL may be more important reservoirs for BLV 
transmission because their blood contains higher concentrations of infected 
lymphocytes than PL-negative cattle. Consequently blood from PL-positive, BLV-
positive cows is likely to be more infectious than blood from PL-negative, BLV-
positive cows.  
Early European eradication programs premised upon the removal of cattle 
with PL and experimental infection trials both have substantiated that increased 
infectivity is associated with increased lymphocyte counts (Bendixen, 1959; 
Ferrer, 1979). Prior to establishing the etiologic agent of enzootic bovine leukosis 
or the development of sensitive and specific serologic assays, many European 
eradication programs focused on the presence of lymphocytosis to target cows 
for culling. Programs that advocated the slaughter of PL-positive cows and those 
that focused on segregation of PL-positive cows both had success (Bendixen, 
1959). Results of experimental infection trials have substantiated this theory by 
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 correlating lymphocyte dose with time to seroconversion and more importantly 
proportion of cattle that become infected after challenge. Results of recent 
studies substantiate that PL-positive cattle are more important as reservoirs of 
BLV. The increase in lymphocyte count seen in PL-positive, BLV-infected cows is 
attributable entirely to proviral-infected lymphocytes (Mirsky et al., 1996). 
 While systematic culling of lymphocytotic cows may rid a herd of BLV, this 
approach is not as practical for herds with a high incidence of BLV-infected cows. 
It is logical to attempt to lower the total virus load on the farm by culling the cattle 
that contribute the most to the overall viral load. Whole herd sampling for 
lymphocyte count is difficult due to the laborious nature of this laboratory 
procedure. Alternatively, ELISA sample-to-positive ratio (S:P) may potentially 
serve as a substitute to measure infectiousness. Multiple serum samples for S:P 
are easier to process and obtain timely results than blood lymphocyte counts, 
particularly because ELISA methods have become automated. 
If the strength of the serologic response to BLV and lymphocyte counts 
are directly related, cattle with a higher S:P with respect to BLV infection would 
be presumed to be more important reservoirs of infection. These cows would 
then be targeted for earlier removal in eradication programs. Prior studies have 
failed to identify associations between serologic recognition by use of the agar 
gel immunodiffusion (AGID) assay and blood lymphocyte counts (Itohara et al., 
1985). Current ELISA technology is better adapted to the exploration of this 
hypothesis because unlike AGID assays, S:P more closely approximates a 
continuous endpoint as a measure of serologic recognition. The purpose of the 
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 study reported here was to determine whether the strength of serologic 
recognition of BLV by use of ELISA was associated with blood lymphocyte 
counts. 
 
MATERIALS AND METHODS 
Cows – Initially, adult cows at the University of Missouri Foremost Dairy 
were tested for BLV status by use of a serum ELISA. All cows that tested positive 
for BLV (n=161, 146 Holstein and 15 Guernsey) were included in the study.  
ELISA – A commercial assay was used to detect BLV antibodies (Bovine 
Leukemia Virus Antibody Test Kit, HerdChek, IDEXX Laboratories, Inc., 
Westbrook, ME). Briefly, the assay used a microtitration format in which BLV 
antigens were bound in the microassay wells. Antibodies within the test sample 
formed a complex with the bound viral antigens during incubation of the sample. 
The sample was washed and an anti-bovine IgG:Horseradish peroxidase 
conjugate was added, which bound to bovine antibody attached to the wells. 
Unbound conjugate was removed by washing. An enzyme substrate and 
chromogen tetramethylbenzidene were added. The absorbance at 620 nm was 
measured spectrophotometrically. A positive test result was defined as S:P >0.5, 
with S:P calculated as follows: 
 
S:P =       (Sample absorbance - negative control absorbance)       
(positive control absorbance- negative control absorbance) 
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 Lymphocyte counts – Blood samples were collected in EDTA-containing 
tubes. Total leukocyte counts were determined with an automatic cell counter 
(Coulter 880 automatic cell counter, Hialeah, FL). Blood films were prepared from 
fresh EDTA-treated blood and stained on an automatic slide stainer (Ames 
Hematek 1000 slide stainer, Bayer Corporation, Elkhart, IN) with Wright's-
Giemsa stain. Differential leukocyte counts were completed via microscopic 
examination and total lymphocyte concentration was calculated as the product of 
total WBC count and lymphocyte proportion determined by differential cell 
counts. 
Data analysis – Sample-to-positive ELISA values were compared between 
lymphocytotic and nonlymphocytotic cows by use of 1-way ANOVA. 
Lymphocytosis status was defined by use of the Bendixen method (Bendixen, 
1959). Thereafter, a forward stepwise regression model was constructed to 
evaluate the association between the dependent variable, blood lymphocyte 
concentration and the independent variables. The independent variables 
included, S:P, age in months, and the interaction of the preceding 2 terms. A p 
value of 0.05 was required for variables to enter the model. At each step, the 
variable with the lowest p value was added to the model. Multiple transformations 
of the dependent and independent variables were performed to determine which 
model best predicted S:P. The model with the highest r2 was chosen as the final 
model.  
A dataset was constructed that contained lymphocyte counts and S:P to 
compare the effects of 3 strategies of removing BLV positive cows from an 
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 endemically infected herd. These strategies included random culling of infected 
cattle, culling based on S:P, and culling based on lymphocyte count. Initially, the 
data set was sorted in descending order on the basis of S:P. Lymphocyte counts 
were summed and the percentage contribution of each cow to the herd total 
lymphocyte count was calculated. A cumulative frequency distribution was 
constructed to evaluate each cow’s contribution to the total lymphocyte pool on 
the basis of S:P. Likewise, a similar cumulative distribution was created on a data 
set, which was sorted from the highest to lowest lymphocyte count. These 
distributions were depicted graphically. Linear regression models were 
developed that predicted cumulative contribution to herd total lymphocyte as a 
function of either S:P or lymphocyte count using the described data sets ordered 
on S:P or lymphocyte count. 
 
RESULTS 
Mean S:P between lymphocytotic (2.58 ± 0.36) and nonlymphocytotic 
(2.38 ± 0.39) cows varied significantly (P<0.003). The regression model which 
best-predicted lymphocyte count was as follows: 
 
Lymphocyte count = 2304.52 + (-38.06) age in months + (2827.06) S:P 
 
Age and S:P were both significantly associated (P < 0.001) with 
lymphocyte count (r2=0.091).  
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 Cumulative group lymphocyte numbers ordered by lymphocyte count and 
S:P are illustrated (Figure 3). Cows with a higher S:P contributed more to the 
total group lymphocyte load, but this increased contribution was not substantial. 
Cows with high lymphocyte counts were scattered throughout the range of S:P. 
 
DISCUSSION 
In the original Danish eradication program, BLV infected herds were 
identified by detection of lymphocytotic cows (Bendixen, 1959; Radostitis et al., 
1994). Once identified, the herd was placed on a mandatory control program. 
Herds on the program were restricted from contact with negative herds. Sale of 
cattle was prohibited with the exception of slaughter, and all contagious material 
from the farm was controlled. Cows were then culled or segregated until 
lymphocytosis could no longer be detected in the herd. By using this simple 
program, national BLV infection dropped to a negligible amount (Radostits, 1994)  
 In cattle infected with BLV, as determined by ELISA (Bovine Leukemia 
Virus Antibody Test Kit, HerdChek, IDEXX Laboratories, Inc., Westbrook, ME), 
S:P and lymphocyte count are related. While the association was significant (P < 
0.001), the magnitude of the association is so small that it should be considered 
of minimal biological relevance. Since the identification of BLV as the causative 
agent in enzootic bovine leukosis, control programs have focused on limiting 
transmission of the virus and culling antibody-positive cows. The concept of 
targeted culling on the basis of lymphocyte count to reduce whole farm virus load 
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 was lost as the hematologic indicators of infection gave way to serologic test 
methods, which offer greater sensitivity.  
 Work has been done demonstrating that BLV can be eradicated from 
infected herds by use of the AGID test. One study revealed that eradication from 
a high-prevalence herd (>30% infected) can be achieved within 90 days 
(Shettigara et al., 1986). However, strict adherence to the protocol was 
necessary. Herds that had even minor noncompliance problems had difficulty 
eradicating the virus. The study protocol included entire-herd testing at 0, 1, 3, 6, 
12, 18, 24, and 30 months. Reactors were to be immediately isolated 200 meters 
from the negative herd and removed from the farm within 30 days. Replacement 
cattle were tested 30 days prior to purchase and within 60 days of being on the 
premises. All new introductions were to be isolated until negative test results 
were obtained. No contact was allowed with cattle from other herds. While this 
protocol clearly allowed for the eradication of the virus, it is not practical for many 
commercial farms. Isolation of cattle requires a separate facility and increased 
personnel hours to care for the cattle until their removal from the farm. The 
rigorous culling of cattle can be financially devastating. The prices that farmers 
currently obtain for cull cows will not cover what they must spend to replace the 
cow with a noninfected cow. The requirement for no contact with cattle from other 
herds will require all cattle that attend shows, exhibitions, sales, or move to 
breeding facilities to be isolated and have 2 negative test results before returning 
to the herd. These strict protocols are unrealistic for many farmers and the 
aggressive culling is financially limiting.  
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 Unfortunately, in herds that have a high incidence of BLV infection, the 
systematic culling of cows on the basis of a positive test status is economically 
prohibitive. Presently, control is focused on preventing further transmission of the 
virus between cows. The random culling of cows on the basis of antibody-
positive status would result in similar proportions of virus being removed from 
farms. For example, if 10% of the cows were culled, 10% of the infectious virus 
would be removed from the herd; if 20% were culled, 20% of the virus would be 
removed.  
Culling cows purely on the basis of S:P should be approached cautiously 
because many high-S:P cows are not lymphocytotic. Conversely, high 
lymphocyte counts were observed in cows with a more modest S:P. Culling 10%, 
20%, and 30% of cattle with the highest S:P would remove 12.4%, 23.3% and 
32.7% of infected-lymphocyte load within a herd, respectively. This is better 
removal of virus load than that achieved by random culling, but the advantage 
gained is less than substantial. 
Alternatively, culling 10%, 20% and 30% of cattle with the highest 
lymphocyte count in a BLV-positive herd would remove 23.9%, 40.1% and 52.4% 
of infected-lymphocyte load within a herd. This means that culling BLV-positive 
cows with high lymphocyte counts may serve as a means to control the amount 
of infectious virus on a farm. This type of targeted culling program in a herd with 
a high prevalence of BLV infection could decrease the amount of virus present 
for the at-risk population, while allowing for more economically acceptable culling 
of cattle with a positive serologic test.  
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 CHAPTER 4 
 
TIMING OF ELISA SEROCONVERSION AND ACQUISITION OF POSITIVE 
POLYMERASE CHAIN REACTION ASSAY RESULTS IN CALVES 
EXPERIMENTALLY INFECTED WITH BOVINE LEUKOSIS VIRUS 
 
 
 
INTRODUCTION 
 Bovine leukosis virus (BLV) is an oncogenic retrovirus of the BLV/HTLV 
group. Approximately 44% of US dairy cattle (NAHMS, 1997) and 10% of US 
beef cattle (NAHMS, 1999) are BLV infected. Cattle infected with BLV mount 
immune responses to both viral surface and core antigens. Consequently, calves 
that ingest colostrum from BLV infected cows will have positive BLV serologic 
test results, regardless of their infection status. Previous studies indicate that 
these positive serologic assay results may persist for as long as 6 months 
(Burridge et al., 1982a) 
Transmission of BLV in the perinatal period can occur in utero (Van Der 
Maaten et al., 1981b; Thurmond et al., 1983a; Piper et al., 1979; Jacobsen et al., 
1983), or through the ingestion of infected colostrum (Piper et al., 1979). In utero 
and colostral infection of the fetus and neonate has been investigated and 
transmission is estimated to be 3%-18% and 12% respectively (Van Der Maaten 
et al., 1981b; Thurmond et al., 1983a; Piper et al., 1979; Jacobsen et al., 1983; 
 49
 Ferrer and Piper, 1981). Infection during parturition has been postulated to occur, 
but has not been investigated in depth. A recent study observed a 33 % 
transmission rate in colostrum deprived calves born to BLV infected cows (Nagy 
et al, submitted). In a control group of colostrum fed calves born to BLV infected 
dams, transmission rate was 0%. It was postulated that the exposure to the virus 
in the colostrum-deprived group occurred at parturition. 
 Blood inoculation of naïve calves by intradermal, intravenous, 
intramuscular, and subcutaneous routes efficiently transmits BLV (Evermann et 
al., 1986). Seroconversion after blood inoculation has been documented to occur 
as early as 3 weeks and as long as 14 weeks (Evermann et al., 1986). Time to 
seroconversion appears to be dose-dependent (Evermann et al., 1986). One 
study demonstrated that seroconversion measured by the AGID lags behind 
PCR identification of provirus by 2-4 weeks (Kelly et al., 1993). Another study 
comparing the AGID, ELISA, and PCR found PCR recognition to occur between 
days 7-56 depending on challenge dose with 3 animals remaining negative by all 
test methods (Klintevall et al., 1994). Seroconversion lagged behind PCR 
conversion in all calves; however, data was not presented to determine if the 
timing was similar for all calves. Most studies comparing serology and PCR 
detection of BLV infection use the AGID as the serologic test comparison. The 
purpose of this study was to determine the time to proviral and antibody detection 
by ELISA in calves after experimental infection. We hypothesized that PCR 
conversion would precede seroconversion. 
 
 50
 MATERIALS AND METHODS 
Calves – Eight colostrum deprived, Holstein bull calves 6 weeks of age or 
older were used for the study. Each calf had 5 sequential, weekly negative ELISA 
and PCR test results prior to being enrolled in the study. 
Infection procedure – Each calf was injected with fresh whole blood in 
ACD from a BLV positive, non-persistent lymphocytosis cow. The inoculum for 
each calf contained approximately 2,000,000 lymphocytes. 
Laboratory specimens –Blood samples for ELISA and PCR assays were 
collected from calves prior to inoculation and weekly thereafter for 7 weeks by 
jugular veinipuncture. Samples for ELISA were collected into tubes with no 
anticoagulant and serum was harvested after centrifugation. Samples for PCR 
assay were collected into tubes containing EDTA.  Samples were stored at 4°C 
and processed within 48 hours.  Lymphocytes were isolated from the whole 
blood samples by use of a commercially available erythrocyte lysis (EL) buffer 
(Erythrocyte lysis buffer, Qiagen Inc, Valencia, CA). Lymphocytes were washed 3 
times with EL buffer and stored at –70ºC for subsequent analysis. The DNA was 
extracted by use of a commercially available kit (QIAamp DNA mini kit, Qiagen 
Inc, Valencia, CA) following the manufacturer’s protocol. 
ELISA – A commercial assay (Bovine leukemia virus antibody test kit, 
ELISA, VMRD Inc, Pullman, WA) was used to detect of BLV antibodies. A 
positive test result was defined as an optical density > the mean of the positive 
controls and a negative test result was defined as an OD < the mean of the 
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 negative controls. For test validation the mean OD of the positive controls was ≥ 
0.250 and the mean OD of the negative controls was ≤ 0.200. 
Polymerase chain reaction assay – Forward (5'-TGG CTA TCC TAA GAT 
CTA CTG-3') and reverse (3'-AGA GGG AAC CCA GTC ACT GTT-5') primers 
were selected on the basis of a published report (Klintevall et al., 1994).  The 
DNA sequences were amplified in a 25-µl reaction mixture containing 0.5µM of 
each primer and 1.0 unit Taq (HotStarTaq, Qiagen Inc, Valencia, CA) DNA 
polymerase in the manufacturer's buffer, which contained 2.0mM MgCl2 and 
0.2mM (each) dNTPs.  The reaction was performed in a programmable 
thermocycler (Perkin-Elmer 9700, Perkin-Elmer Inc, Shelton, CT) An initial 
incubation of 12 minutes at 95ºC was followed by 10 cycles of denaturation at 
95ºC for 30 seconds, annealing at 70ºC for 30 seconds, and extension at 72ºC 
for 90 seconds. Annealing temperature was reduced by 1ºC each cycle.  An 
additional 30 cycles of denaturation at 95ºC for 30 seconds, annealing at 58ºC 
for 30 seconds, and extension at 72ºC for 90 seconds were performed, followed 
by a final extension at 72ºC for 7 minutes. Amplification with BLV-specific primers 
yielded a product of 330 bp.  Amplification products were isolated in a 2% 
agarose gel and stained with ethidium bromide (Sambrook et al., 1989). Each 
batch was performed with known positive and negative samples as controls. 
Data Analysis – Mean and median times to PCR and seroconversion were 
calculated. At each sampling time the sensitivity of PCR and ELISA in the 
detection of early post-infection events was calculated. At each sampling time the 
cumulative sensitivity, defined as the proportion of calves with at least one 
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 positive test using the assay under consideration, was calculated. The proportion 
of calves identified as infected by cumulative weekly testing results using the 
ELISA and PCR were compared at each sampling time using a Fischer’s exact 
test.  An approximation of ELISA sensitivity in known infections was calculated by 
dividing the number of positive tests by the number of total tests in calves with 
previous positive ELISA results. A similar calculation was performed for the PCR 
assay. 
 
RESULTS 
All 8 calves became infected with BLV. Each calf had a minimum of 4 
positive ELISA test results and 1 positive PCR results prior to the completion of 
the study. The total weeks to PCR and seroconversion are presented (Table 3). 
In 5 calves PCR conversion for BLV status preceded seroconversion. 
Seroconversion preceded PCR conversion in 2 calves. In 1 calf both tests 
became positive at the same test date. Once antibodies were detected, animals 
were consistently seropositive for the remainder of the study, equivalent to a 
sensitivity of 1.00. Six calves had at least 1 false negative PCR test after the 
initial positive result. After initial positive PCR results 20 of 30 total tests were 
positive, analogous to a sensitivity of 0.67 in the detection of documented 
infections. The proportion of calves identified as infected by cumulative weekly 
testing results using ELISA and PCR were not significant at any of the sampling 
times and only approached significance (P = 0.08) at 2 week post-infection 
(Table 4). 
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 DISCUSSION 
 In this study, the ability of PCR to detect early infection with BLV after 
experimental inoculation was evaluated.  Positive test results were observed 
earlier using the PCR. Four of 8 calves had positive test results within 2 weeks 
post-infection and no positive ELISA results were observed until week 3. The 
ranges in times to seroconversion and proviral detection by PCR were similar to 
that reported in adult cattle with low challenge exposure. Mean and median 
conversion with the PCR was faster than with the ELISA. However, the difference 
in conversion time is probably not clinically important. In addition, 3 animals 
demonstrated positive antibody prior to proviral detection by PCR. At least 1 false 
negative PCR test result after initial provirus detection was present in 6 calves. 
This is consistent with the reported sensitivity of the assay (Nagy et al., 2003). In 
contrast no calves had a negative ELISA after their first positive ELISA result.  
The PCR holds few advantages over ELISA based serology for early 
identification of infected adult animals. Assessing all possible measures of 
sensitivity, either cumulative sensitivity with serial testing programs or point 
sensitivity, the ELISA will detect a higher proportion of infected adults than will 
the PCR. Cost and the ease with which the ELISA is adapted to mass sample 
processing also support the routine use of serology to identify infected cattle. 
If this infection model is representative of natural exposure, the time to 
seroconversion may be shorter than previously thought. It is possible that the 
ELISA assay is able to detect infections prior to the AGID assays that were used 
in previous studies. Alternatively, the challenge dose may be higher than that 
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 present in natural exposure. The larger challenge dose may result in shorter 
times to seroconversion and earlier detection of infection. If the model is truly 
representative, the results of this study suggest that a single negative ELISA test 
result at 5 weeks after a quarantine period, should provide sufficient assurance 
that the animal is truly BLV negative.  
 Despite the failure of the PCR to identify all animals prior to 
seroconversion, some clinical utility to the use of PCR remains. The PCR may 
still be used as a confirmatory test in animals of exceptional value that may 
otherwise be culled due to a positive serologic test. Additionally, testing premised 
upon viral identification may become critically important if vaccines are 
developed and marketed for BLV. Under these circumstances vaccines may 
produce positive serologic tests results and more definitive viral detection 
methods may become necessary. 
The PCR also may play a role in the identification of infection in neonatal 
calves that have absorbed BLV antibodies through colostrum. The ability to 
identify provirus will allow for the identification and removal of infected calves 
prior to commingling and processing events that allow for the amplification of low 
level infections.  It should be noted that serial weekly testing detected BLV 
infection in 50% of calves within 2 weeks post-infection and 100% of calves by 5 
weeks post-infection. On most modern dairy farms calves typically housed singly 
in calf hutches until 8-10 weeks of age. Under these conditions the potential for 
horizontal transmission is negligible. We envision the development of programs 
in which calves infected transplacentally, at parturition, or by ingestion of 
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 colostrum may be detected using the serial PCR testing cycles and culled, 
producing BLV negative cohorts with minimal risk for horizontal transmission. 
This strategy is particularly attractive because recent studies have 
suggested that the ingestion of colostrum from positive cows may have profound 
effects in the prevention of parturition associated BLV transmission. In this study 
provision of frozen colostrum from BLV positive cows resulted in a 0% neonatal 
transmission rate. While, colostrum deprived calves born to infected cows had a 
30% neonatal transmission rate. These results suggest that either depriving 
calves of colostrum or providing colostrum from BLV – negative cows may in fact 
be counterproductive in the development of comprehensive BLV control 
strategies. 
 The ability to raise BLV negative replacement heifers is crucial to control 
and eradication programs in endemically infected herds. Serology is superior to 
other test methods for routine identification of infected animals. To date the 
suggested utilities attributed to PCR have not gained widespread use. 
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 CHAPTER 5 
 
ENHANCED PERIPARTURIENT TRANSMISSION OF BOVINE LEUKOSIS 
VIRUS IN COLOSTRUM – DEPRIVED CALVES 
 
 
 
INTRODUCTION 
Bovine leukosis virus (BLV) is an oncogenic retrovirus that is highly 
homologous to human T cell lymphotropic virus 1 and 2 (HTLV-1, HTLV-2). 
Approximately 44% of dairy cattle and 10% of beef cattle in the United States are 
BLV infected (NAHMS, 1997; NAHMS 1999). The primary disease manifestation 
of BLV infection is the development of lymphosarcoma in approximately 5% of 
BLV infected cattle (Ferrer et al., 1979b). Any practice that transfers lymphocytes 
from infected to naïve cattle potentially spreads the virus. Dehorning (DiGiacomo 
et al., 1985; Lassauzet et al., 1990), tattooing (Lucas et al., 1985), rectal 
palpation (Henry et al., 1987; Hopkins et al., 1988; Divers et al., 1994), and 
bleeding for diagnostic tests (Wilesmith 1978; Maas-Inderwiesen, 1978) have 
been implicated in viral transmission. Arthropod vectors (Bech-Nielsen, 1978; 
Buxton et al., 1982; Ohshima et al., 1981; Buxton et al., 1985; Manet et al., 
1989), colostrum ingestion (Ferrer and Piper, 1981), and transplacental 
transmission (Van Der Maaten et al., 1981b; Thurmond et al., 1983a; Piper et al., 
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 1979; Jacobsen et al., 1983) also have been incriminated as modes of 
transmission. 
  The relationship between calf infection status and colostrum ingestion is 
not entirely clear. Two divergent conclusions have been drawn from previous 
studies. The first suggests that colostrum ingestion may transmit BLV to neonatal 
calves (Miller and Van Der Maaten, 1979; Ferrer and Piper, 1981). The second 
suggests that colostral antibodies protect against neonatal infection (Van Der 
Maaten et al., 1981a; Lassauzet et al., 1989a). Infected lymphocytes are present 
in both colostrum and milk of BLV infected cattle (Parfanovich et al., 1978; Ferrer 
et al., 1981; Kenyon et al., 1982). Oral ingestion of infected blood origin 
lymphocytes can transmit the virus early in life and the cellular component of 
colostrum and milk is capable of transmitting the virus when injected parenterally 
(Van Der Maaten et al., 1981a; Baumgartener et al., 1976). Despite this being an 
unnatural route of exposure, these studies highlight the potential for the 
transmission of the virus through infected colostrum and milk. This is of particular 
concern during the first 24 hours of life when the neonatal bovine gut permits the 
absorption of intact macromolecules and cells.  
 
MATERIALS AND METHODS 
  Animals – 12 colostrum – deprived Holstein calves 6 weeks of age or 
older and 20 colostrum – fed Holstein calves were used in the study. All calves 
were born to BLV infected cows. All colostrum – deprived calves had 6 weekly 
ELISA and PCR tests for BLV antibody and provirus completed. All colostrum – 
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 fed calves were fed colostrum derived from BLV positive cows and had positive 
serum ELISA test results after ingestion of colostrum. Thereafter, colostrum – fed 
calves had ELISA and PCR tests for BLV antibody and provirus performed every 
other week until 2 consecutive negative ELISA tests were achieved or until 1 
positive PCR tests were achieved. 
Laboratory specimens – Blood samples were collected by jugular 
veinipuncture for ELISA and PCR assays for bovine leukosis virus. Enzyme 
linked immunosorbant assay samples were collected into tubes with no 
anticoagulant. Polymerase chain reaction assay samples were collected into 
tubes containing EDTA.  All samples were stored at 4°C and processed within 48 
hours.  Lymphocytes were isolated by use of a commercially available 
erythrocyte lysis (EL) buffer (Erythrocyte lysis buffer, Qiagen Inc, Valencia, CA). 
Lymphocytes were washed 3 times with EL buffer and stored at –70ºC for 
subsequent analysis. The DNA was extracted by use of a commercially available 
kit (QIAamp DNA mini kit, Qiagen Inc, Valencia, CA) following the manufacturers’ 
protocol. 
ELISA – A commercial assay (Bovine leukemia virus antibody test kit, 
ELISA, VMRD Inc, Pullman, WA) was used to detect of BLV antibodies. A 
positive test result was defined as an optical density > the mean of the positive 
controls and a negative test result was defined as an OD < the mean of the 
negative controls. For test validation the mean OD of the positive controls was ≥ 
0.250 and the mean OD of the negative controls was ≤ 0.200. 
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  Polymerase chain reaction assay – Forward (5'-TGG CTA TCC TAA GAT 
CTA CTG-3') and reverse (3'-AGA GGG AAC CCA GTC ACT GTT-5') primers 
were selected on the basis of a published report (Klintevall et al., 1994). The 
DNA sequences were amplified in a 25-µl reaction mixture containing 0.5µM of 
each primer and 1.0 unit Taq (HotStarTaq, Qiagen Inc, Valencia, CA) DNA 
polymerase in the manufacturer's buffer, which contained 2.0mM MgCl2 and 
0.2mM (each) dNTPs.  The reaction was performed in a programmable 
thermocycler (Perkin-Elmer 9700, Perkin-Elmer Inc, Shelton, CT). An initial 
incubation of 12 minutes at 95ºC was followed by 10 cycles of denaturation at 
95ºC for 30 seconds, annealing at 70ºC for 30 seconds, and extension at 72ºC 
for 90 seconds. Annealing temperature was reduced by 1ºC each cycle.  An 
additional 30 cycles of denaturation at 95ºC for 30 seconds, annealing at 58ºC 
for 30 seconds, and extension at 72ºC for 90 seconds were performed, followed 
by a final extension at 72ºC for 7 minutes.  Amplification with BLV-specific 
primers yielded a product of 330 bp.  Amplification products were isolated in a 
2% agarose gel and stained with ethidium bromide (Sambrook et al., 1989). Each 
batch was performed with known positive and negative samples as controls. This 
procedure has been previously described (Nagy et al., 2003). 
Data Analysis –The proportion of calves that converted to BLV positive 
status was calculated for each group. In the colostrum – deprived group, calves 
were classified as infected when a positive test result by either assay was 
obtained. In the colostrum fed group, calves were classified as infected or true 
positives when a positive PCR was obtained. The proportion of calves becoming 
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 infected with BLV was compared among the 2 treatment groups using a Fischer’s 
exact test. 
 
RESULTS 
In the colostrum deprived group, 4/12 (33%) calves converted to BLV 
positive status. Each BLV positive colostrum–deprived calf had a minimum of 2 
positive ELISA tests and 1 positive PCR tests by the end of the study. In the 
colostrum fed group, 0/20 (0%) calves converted to BLV positive status. The 
proportion of calves that became infected with BLV was significantly higher in the 
colostrum deprived group (p=0.01). 
 
DISCUSSION 
 In this study, the difference in BLV prevalence in BLV antibody positive 
colostrum-fed and colostrum-deprived calves was evaluated. Prevalence of 
infection was higher in the colostrum-deprived calves suggesting that the 
administration of BLV positive colostrum reduces the risk of infection relative to 
deprivation. Based on previous studies the sensitivity of the serial testing 
protocols employed should exceed 99% (Nagy et al., 2003). It should be noted 
that similar methodology determining the source of neonatal infection has been 
used in numerous human studies.  
 It is impossible to determine the exact timing of viral exposure in the 
colostrum deprived calves. It is unlikely that the exposure occurred in utero 
because a similar infection rate would be expected in the colostrum fed calves. 
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 Additionally, reported in utero transmission rates are dramatically lower than the 
transmission rates observed in the present study, ranging from 0 – 20% (Van Der 
Maaten et al., 1981b; Jacobsen et al., 1982; Kono et al., 1983; Piper et al., 
1979). Most studies report BLV transmission rates from ranging from 0 – 4% 
(Van Der Maaten et al., 1981b; Jacobsen et al., 1982). This disparity suggests 
that the vast majority of transmission observed in the present study occurred 
during or after birth. The negative PCR and serology results in the early 
postpartum period substantiate this conclusion. The difference in transmission 
rates between colostrum–fed and colostrum–deprived calves eliminates 
colostrum transmission as a source of infection. Hence, we are left with the 
conclusion that parturition results in exposure to BLV and administration of 
colostrum greatly ameliorates the risk of infection. The mechanism of this 
protection may be passively transferred humoral immunity or the transfer of 
immunologically active lymphocytes via colostrum.  
Vertical transmission is thought to be a critical factor in maintenance of 
HTLV-1 in affected populations. Studies of vertical transmission have 
documented rates as high as 21 and 33% (Tsuji et al., 1990; Ando et al., 2003). 
The majority of this transmission is thought to occur through prolonged breast 
feeding of greater than 6 months (Furnia et al., 1999; Tsuji et al., 1990). One 
study that followed infants of infected mothers found that maternal origin HTLV-1 
antibody disappeared in positive infants by 6 months of age. In these infants 
infection origin antibodies began to appear after 6 months and the number of 
positive infants rose until 2 years after which infection status of the child 
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 remained static (Tsuji et al., 1990). In a study using PCR to detect provirus, the 
earliest estimate of infection was 5.8 months (Furnia et al., 1999). It is important 
to recognize that this is a presumptive date that was derived by splitting the time 
from the last negative test result to the first positive test result so this infection 
may have actually occurred several months earlier or later than this estimate.  
 In humans, breastfeeding has long been considered a risk factor for the 
transmission of retroviral diseases including HTLV-I and II, and HIV (Tsuji et al., 
1990; Read, 2003; Newell, 2004). However, it should be noted that similar to the 
study presented here, a number of studies support a protective role of 
breastfeeding against retroviral transmission (Coutsoudis et al., 1999; Hisada et 
al., 2002; lliff et al., 2005). One recent study found a decreased risk of HIV 
transmission in infants that were exclusively breastfed when compared to those 
that were predominantly breast fed or had mixed feedings from multiple mixed 
sources (Iliff et al, 2005). Infants with mixed feeding sources had a 4.03, 3.79, 
and 2.60 greater risk of being HIV infected at 6, 12, and 18 months, respectively 
when compared to infants that were exclusively breastfed. Another study found 
transmission rates of 21.3%, 24.1%, and 14.6% in 3-month-old infants that had 
no breast feeding, mixed source feeding, and exclusive breast feeding, 
respectively (Coutsoudis et al., 1999). When evaluated as a group, these studies 
suggest that high serum immunoglobulins in the neonate at the time of retroviral 
exposure is likely protective. Additionally, these studies suggest that as these 
maternally derived colostral and milk immunoglobulins decline the risk of 
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 contracting BLV, HIV, or HTLV in the respective species, increases (Ando et al., 
2003; Iliff et al., 2005).  
Currently, targeted antiviral protocols are the cornerstone of mother-to-
child HIV prevention protocols. These are not without risks, as some protocols 
have been associated with increased postpartum drug resistance in the mother 
(Eshleman and Jackson, 2002).The targeted administration of high levels of anti-
HIV antibodies to these protocols may afford additional protection to exposed 
infants or provide prophylaxis without selection fro maternal drug resistance. 
 In this study the administration of colostrum from BLV positive cows 
exerted substantial protection against infection following parturition associated 
exposure. This information is critical when considering calf centered control 
programs for BLV infection.  Recommendations to feed colostrum from BLV 
negative cows when available are commonplace (Brunner et al., 1997). These 
recommendations stem from the assumption that colostrum is infectious. 
However, the results of this study suggest that efforts to feed colostrum from BLV 
negative dams or the use of colostrum replacers have the potential to increase 
neonatal transmission of BLV. 
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 CHAPTER 6 
 
DECAY OF COLOSTRALLY DERIVED BOVINE LEUKOSIS VIRUS 
IMMUNOGLOBULINS IN NEONATAL CALVES 
 
 
 
INTRODUCTION 
Bovine leukosis virus (BLV) is an oncogenic retrovirus of cattle that shares 
a high degree of homology with human T cell lymphotropic virus 1 and 2 (HTLV-
1, HTLV-2). The virus primarily infects B lymphocytes; although T lymphocytes 
also may be infected (Williams et al., 1988; Mirsky et al., 1996). Transfer of 
lymphocytes from infected to naïve cattle spreads the virus. Many common 
practices including dehorning (DiGiacomo et al., 1985), tattooing (Lucas et al., 
1985), rectal palpation (Hopkins et al., 1988; Divers et al., 1994), and bleeding 
for diagnostic tests (Wilesmith et al., 1978) have been implicated in viral 
transmission. Arthropod vectors (Buxton et al., 1985; Manet et al., 1989), 
colostrum ingestion (Straub, 1982), and transplacental infection (Van Der Maaten 
et al., 1981b; Jacobsen et al., 1983; Miller et al., 1979; Ferrer and Piper, 1981) 
also have been incriminated as important modes of transmission. Close contact 
with BLV infected animals is considered a primary risk factor in the development 
of persistent BLV infection (Straub, 1978). 
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 In commercial herds with a low prevalence of BLV infection, control and 
eradication programs are straightforward and easily implemented. Adult and 
juvenile cattle (> 6 months of age) are tested using available serologic assays 
and cattle with positive test results are removed from the herd. Such programs 
will generally have remarkable progress causing dramatic decreases in the 
prevalence of BLV infection. In herds with a high prevalence of BLV infection, 
test and slaughter programs are economically untenable, particularly in the 
absence of state or federal indemnity programs.  
 Despite the presence of testing modalities that are both sensitive and 
specific for BLV, identifying neonatal infection with the virus has been 
problematic (Burridge et al., 1982a; Evermann and Jackson, 1997; Ferrer et al., 
1977; Johnson an Kaneene, 1991a; Monke et al., 1992). The issue which is most 
problematic is the passive transfer of antibodies that occurs from the dam to the 
neonate upon the ingestion of colostrum. The majority of tests detect BLV 
indirectly by testing for the presence of antibody (Johnson and Kaneene, 1991c). 
Once a calf has ingested colostrum from a positive dam; these tests are 
rendered useless in determining calf virus status. It was once thought that the 
advent of PCR would eliminate this concern because the PCR would detect 
integrated BLV provirus despite the presence of maternal antibody (Agresti et al., 
1993; Brandon et al., 1991; Eaves et al., 1994; Kelly et al., 1993; Marsolais et al., 
1994; Naif et al., 1992; Sherman et al., 1992). However, inadequate sensitivity 
and high test cost associated with the PCR decrease the clinical utility of this 
test. 
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  In addition to recognition of infected animals, understanding the decay of 
colostral origin BLV antibodies would be important to determine appropriate 
vaccination protocols for calves should a vaccine become available. Colostral 
antibody decay curves for BLV antibody have not been established using ELISA 
methodology although they have been established using the AGID (Thurmond et 
al., 1982; Johnson et al., 1987). It is possible that differences exist due to the 
increased sensitivity of the ELISA.  
 The objective of this study is to generate a decay curve for antibodies 
recognizing BLV in neonatal calves fed colostrum from BLV-infected cows. The 
curve will allow more accurate interpretation of BLV serology in youngstock, 
creating an additional tool for identifying active BLV infection in calves less than 6 
months of age. 
 
MATERIALS AND METHODS 
Calves – Seven heifer calves born to BLV positive dams were enrolled in 
this study. Each calf was bottle fed pooled colostrum from BLV positive cows ad 
libidum divided into 2 2-liter feedings.  
Sample collection – Blood samples for ELISA and PCR assay were 
collected prior to colostrum ingestion. Samples for ELISA were collected into 
tubes without anticoagulant. Serum was separated and stored at 4°C for further 
analyses. Samples for PCR assay were collected into tubes containing EDTA. 
Samples were stored at 4°C and processed within 48 hours. Additional serum 
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 samples were collected at day 2, 30, 60, and then every 2 weeks until 2 
consecutive negative test results were obtained. 
Serum ELISA recognizing BLV - A commercial assay (Bovine leukemia 
virus antibody test kit, ELISA, VMRD Inc, Pullman, WA) was used to detect of 
BLV antibodies. A positive test result was defined as an optical density > the 
mean of the positive controls and a negative test result was defined as an OD < 
the mean of the negative controls. For test validation the mean OD of the positive 
controls was ≥ 0.250 and the mean OD of the negative controls was ≤ 0.200. 
Blood PCR recognizing BLV - Forward (5'-TGG CTA TCC TAA GAT CTA 
CTG-3') and reverse (3'-AGA GGG AAC CCA GTC ACT GTT-5') primers have 
been selected based on a previously published report (Klintevall et al., 1994). 
The DNA sequences were amplified in a 25µl reaction mixture containing 0.5 µM 
of each primer, 1.0 units HotStarTaq in the manufacturer's buffer containing 2.0 
mM MgCl2 and 0.2 mM (each) dNTPs. The reaction was performed in a 
programmable thermocycler. An initial incubation of 12 minutes at 95ºC will be 
followed by ten cycles of denaturation at 95ºC for 30 seconds, annealing at 70ºC 
for 30 seconds, and extension at 72ºC for 90 seconds. The annealing 
temperature was reduced by 1ºC each cycle. An additional 30 cycles of 
denaturation at 95ºC for 30 seconds, annealing at 58ºC for 30 seconds and 
extension at 72ºC for 90 seconds was performed followed by a final extension at 
72ºC for 7 minutes. Amplification with the BLV-specific primers yielded a product 
of 330 bp. Amplification products were visualized in a 2% agarose gel by 
ethidium bromide staining and ultraviolet transillumination (Sambrook et al., 
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 1989). Each sample was performed in tandem with known positive and negative 
control samples. This technique has been validated in populations of known 
positive and negative status (Nagy et al., 2003). 
Data analysis – For each calf a log linear regression line was calculated 
from the data using a statistical software package. The half life of BLV antibodies 
in each calf was the calculated using the following equation: 
 
T1/2=[log10(10a/2) - a]/b 
 
Where a is the y-intercept and b is the slope of the regression line. The mean, 
median, standard deviation, and 95% confidence interval of the half-life were 
calculated. For each calf a linear regression line was calculated to determine the 
slope of the antibody decay curve and the standard deviation of said slope. Mean 
slope and standard deviation of slope was calculated. Anticipated decay curves 
were constructed for calves premised upon known initial (48 hr) BLV ELISA 
optical density and calf age at the time of sampling.  
 
RESULTS 
All calves were BLV negative by 105 days. The calculated half-life of BLV 
antibodies in the calves ranged from 31 – 76 days with a mean of 48.5 days, a 
median of 47.3 days, and a standard deviation of 15.6 days. The 95% confidence 
interval for the half-life mean was (34.1, 62.9). The serum BLV antibody decay is 
depicted in figure 4. 
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 DISCUSSION 
Disease control and eradication requires accurate, definitive tests that are 
able to identify infected animals early in the course of infection. Historically, BLV 
control and eradication programs have not addressed neonatal calves because 
of the inability to assess BLV status in calves that have ingested colostrum from 
BLV-positive cows. Prolonged false positive tests due to the interference of 
colostrally acquired BLV antibody limits the use of the AGID and ELISA. While, 
the PCR allows for accurate identification of infected animals in the presence of 
maternal antibody, the current cost of a BLV PCR limits use of the test. 
Determining the natural decay of colostrally derived BLV antibodies in neonatal 
calves may allow for earlier identification of infected calves using serologic 
methods.  
The time for all calves to reach BLV negative status was in between the 2 
AGID based studies previously reported (Thurmond et al., 1982; Johnson et al., 
1987). The range of calculated half lives in the current study is broader and 
higher than initially expected. The published decay of colostral IgG1 in calves 
ranges from 18 – 22 days, with BLV specific antibody decay falling at 25.8 and 
36 days (Thurmond et al., 1982; Johnson et al., 1987). Several factors may 
account for the differences seen. The present study used optical density test 
values from the ELISA while previous BLV antibody decay rates have been 
determined using the AGID. It has also been postulated that variability may be 
due to the variability of BLV antibodies in individual cow colostrum. Studies have 
documented increased time to test negative status in calves that received 
 70
 colostrum from cows with higher BLV titers on the day of parturition (Johnson, et 
al., 1987) and in calves with initial high colostral antibody titers (Lassauzet et al., 
1990c). Immunoglobulin decay should be constant. For that reason time to test 
negative status may vary by total amount of immunoglobulin ingested at birth, but 
half life should not.  
With the clinical availability of PCR the current study was also able to have 
a more definitive definition of a negative calf by looking for detectable provirus 
rather than relying on serial negative serotests. In addition decay of colostral 
immunoglobulins is curvilinear. Each calf in the study reported here had a 
minimum of 5 ELISA tests while previous work included some subjects with as 
few as 3 tests (Thurmond et al., 1982; Johnson et al., 1987). The increased 
number of test points will more accurately reflect the curvilinear nature of 
antibody decay extending the calculated half-life. 
In the current study the development of a decay curve for colostrally 
derived BLV antibodies in calves will allow for estimation of BLV status in the 
face of colostral antibodies. Calves with half lives substantially longer than 48 
days are likely to have endogenous anti-BLV antibodies production. This is 
suggestive of active infection with BLV. The practical utility of this model remains 
unproven. 
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 CHAPTER 7 
 
CONCLUSIONS 
 
 
Performance of the PCR assay is promising and it may provide a useful 
adjunct to traditional testing programs. However, in most circumstances serologic 
tests will be superior to the PCR assay because higher sensitivity (> 95%) will 
expedite identification of BLV-infected animals. Potential applications of the PCR 
assay may be restricted to 2 specific situations in clinical practice. First, the PCR 
assay could be used to detect BLV in neonatal calves with passive transfer of 
maternal antibodies against BLV. Second, the PCR assay could be used as a 
confirmatory test in valuable animals that may otherwise be culled as a result of a 
positive serologic test. Use of the PCR to identify cattle that were recently 
exposed to BLV seemed like an initial promise of this modality, but did not 
outperform serology to the point that it would have a lot of clinical utility.  
Serial testing could be used to increase the accuracy of testing 
procedures when applying a PCR assay to BLV control programs. Serial PCR 
assays can decrease the rate of false negative tests. In populations with low 
prevalence of BLV, 2 consecutive tests will reduce the false negative rate to an 
acceptable level, whereas 3 consecutive tests will reduce prevalence to a 
clinically unimportant level. In populations with high prevalence of BLV, serial 
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 testing could improve the ability to identify all infected cattle. However, serologic 
methods of BLV detection are more sensitive for routine screening of adult cattle. 
Historically the detection of lymphocytosis has been used to drop BLV 
prevalence to negligible levels in infected herds. However, the development of 
more sensitive and specific tests had limited the use of this potentially powerful 
diagnostic tool. The random culling of cows on the basis of antibody-positive 
status would result in similar proportions of virus being removed from farms. For 
example, if 10% of the cows were culled, 10% of the infectious virus would be 
removed from the herd; if 20% were culled, 20% of the virus would be removed. 
Culling 10%, 20%, and 30% of cattle with the highest S:P would remove 12.4%, 
23.3% and 32.7% of infected-lymphocyte load within a herd, respectively. This is 
better removal of proviral load than that achieved by random culling, but the 
advantage gained is less than substantial. Alternatively, culling 10%, 20% and 
30% of cattle with the highest lymphocyte count in a BLV-positive herd would 
remove 23.9%, 40.1% and 52.4% of infected-lymphocyte load within a herd. This 
means that culling BLV-positive cows with high lymphocyte counts may serve as 
a means to control the amount of infectious provirus on a farm. This type of 
targeted culling program in a herd with a high prevalence of BLV infection could 
decrease the amount of provirus present for the at-risk population, while allowing 
for more economically acceptable culling of cattle with a positive serologic test. 
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 APPENDIX 
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 Table 1 – Bendixen hematologic key for the classification of cattle as leukotic 
(Bendixen, 1959). 
 
 
 
 
 
Age 
in years 
Group I 
Normal 
Group II 
Dubious 
Group III  
Leucaemic 
0-1 < 10,000 10,000 – 12,000 > 12,000 
1-2 < 9,000 9,000 – 11,000 > 11,000 
2-3 < 7,500 7,500 – 9,500 > 9,500 
3-4 < 6,500 6,500 – 8,500 > 8,500 
4-5 < 5,000 5,000 – 7,000 > 7,000 
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 Table 2 – Summary of slaughter data for 1998 – 2002 for condemnations due to 
lymphosarcoma. 
 
 
 
 
Year Slaughter 
category 
Number 
slaughtered 
  Number 
condemned 
Lymphosarcoma
Condemnations 
1998 Bulls and 
stags 
615,888 1,608 209 
 Steers 16,202,791 14,144 204 
 Cows 5,886,745 130,470 20,907 
 Heifers 10,567,435 10,902 133 
Annual total  32,718,559 157,124 21,453 
1999 Bulls and 
stags 
601,652 1,877 96 
 Steers 16,647,224 18,348 141 
 Cows 5,342,619 112,993 19,479 
 Heifers 11,088,609 22,057 94 
Annual total     
2000 Bulls and 
stags 
619,616 2,012 97 
 Steers 17,457,463 23,436 209 
 Cows 5,269,576 142,874 24,070 
 Heifers 11,789,720 20,592 164 
Annual total     
2001 Bulls and 
stags 
706,958 2,202 125 
 Steers 18,363,668 17,339 314 
 Cows 6,214,474 165,881 28,315 
 Heifers 12,355,710 12,801 214 
Annual total     
2002 Bulls and 
stags 
610,130 1,484 102 
 Steers 15,621,561 11,988 276 
 Cows 5,175,861 143,484 25,037 
 Heifers 9,996,325 8,915 121 
Annual total     
Total     
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Table 3 – Time to seroconversion and the detection of provirus by PCR in calves 
experimentally inoculated with BLV. 
 
 
Weeks to first positive test Calf number 
PCR ELISA 
1 2 3 
2 3 5 
3 5 4 
4 5 3 
5 4 4 
6 2 4 
7 2 3 
8 2 3 
Mean 3.125 3.625 
Median  2.5 3.5 
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 Table 4 – Proportion of calves identified as infected by cumulative testing using 
the ELISA and PCR in calves experimentally infected with BLV.  
 
 
Cumulative sensitivity Time 
PCR ELISA 
Week 1 0.00 0.00 
Week 2 0.50 0.00 
Week 3 0.63 0.50 
Week 4 0.75 0.88 
Week 5 1.00 1.00 
Week 6 1.00 1.00 
Week 7 1.00 1.00 
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Figure 1 – Positive (solid line; PPV) and negative (dotted line; NPV) predictive 
values of a polymerase chain reaction (PCR; sensitivity, 0.672; specificity, 1.00) 
assay for all possible prevalences of infection for cows infected with bovine 
leukosis virus (BLV). 
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 Figure 2 – Theoretical estimates of prevalence for cattle serially tested via PCR 
assay for BLV infection status in 3 populations with varying initial prevalence.  
Prevalence of 5% (closed circles), 10% (open circles), 15% (closed triangles). 
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Figure 3 – Graph of the cumulative proportion of herd total lymphocyte count 
versus the cumulative proportion of the herd that would be removed by targeted 
culling versus random culling in a herd of cattle with bovine leucosis virus  (BLV) 
infection. 
 
a- Targeted culling of BLV positive cows based on lymphocyte count from 
highest to lowest. 
b- Targeted culling of BLV positive cows based on S:P ELISA from highest to 
lowest.  
c- Random culling of cows with positive results of ELISA for BLV.  
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 Figure 4 – Theoretical decay curve of colostral origin BLV antibodies in neonatal 
calves. 
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